<SEC-DOCUMENT>0001615219-22-000081.txt : 20220512
<SEC-HEADER>0001615219-22-000081.hdr.sgml : 20220512
<ACCEPTANCE-DATETIME>20220512161406
ACCESSION NUMBER:		0001615219-22-000081
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220512
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220512
DATE AS OF CHANGE:		20220512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Salarius Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001615219
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				465087339
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36812
		FILM NUMBER:		22917957

	BUSINESS ADDRESS:	
		STREET 1:		2450 HOLCOMBE BLVD
		STREET 2:		SUITE J-608
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77021
		BUSINESS PHONE:		346-772-0346

	MAIL ADDRESS:	
		STREET 1:		2450 HOLCOMBE BLVD
		STREET 2:		SUITE J-608
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Flex Pharma, Inc.
		DATE OF NAME CHANGE:	20140730
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>flks-20220512.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:b39be0aa-e8b5-4363-a343-a7c7e78eeb90,g:25e805b9-63b1-4011-a802-8e989fd7d5b7,d:5b76934489b84ce5aa82a6cc52281968--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>flks-20220512</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF80L2ZyYWc6MjMwNjkyMjExODRhNGEwZThiMDhkZDczYWU1ZWFkMTIvdGFibGU6OGE1NWJiYTM1MmQ3NDUxOWJiZGUzYjAwZjcyYjNiZGEvdGFibGVyYW5nZTo4YTU1YmJhMzUyZDc0NTE5YmJkZTNiMDBmNzJiM2JkYV8xLTEtMS0xLTIxOTQ2_37c2a4f8-c830-487d-9f3f-de15bad61aab">0001615219</ix:nonNumeric><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF80L2ZyYWc6MjMwNjkyMjExODRhNGEwZThiMDhkZDczYWU1ZWFkMTIvdGFibGU6OGE1NWJiYTM1MmQ3NDUxOWJiZGUzYjAwZjcyYjNiZGEvdGFibGVyYW5nZTo4YTU1YmJhMzUyZDc0NTE5YmJkZTNiMDBmNzJiM2JkYV8yLTEtMS0xLTIxOTQ2_3c8ed883-21ff-4a64-a454-ea84728db03d">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="flks-20220512.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001615219</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-12</xbrli:startDate><xbrli:endDate>2022-05-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5b76934489b84ce5aa82a6cc52281968_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:133%">SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">Washington, D.C.&#160; 20549</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGV4dHJlZ2lvbjpkNGExNTZkYzRmMzM0ZjViOWEzZThiMjczY2QzYmViZl8yMjMz_045bd17d-a73f-45ae-9a72-1f501cc96906">8-K</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT<br/>Pursuant to Section 13 or 15(d) of the<br/>Securities Exchange Act of 1934</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGV4dHJlZ2lvbjpkNGExNTZkYzRmMzM0ZjViOWEzZThiMjczY2QzYmViZl8yMDk_19b4318c-ac6f-4344-afad-ec77f805e632">May 12, 2022</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGV4dHJlZ2lvbjpkNGExNTZkYzRmMzM0ZjViOWEzZThiMjczY2QzYmViZl8yMjM0_4e0ee0dd-e27d-4c65-a86c-72d7d077361e">SALARIUS PHARMACEUTICALS, INC.</ix:nonNumeric> <br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8wLTAtMS0xLTIxOTQ2_dc6988a4-21dc-48f3-8489-53b72c667b9d">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8wLTItMS0xLTIxOTQ2_4b1231fd-717c-4d3b-88df-08ab7a0233a0">001-36812</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8wLTYtMS0xLTIxOTQ2_2b058e50-e146-4441-b053-4f0a32a20014">46-5087339</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(IRS Employer Identification Number)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.05pt;margin-top:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8zLTAtMS0xLTIxOTQ2L3RleHRyZWdpb246OGYzMTc1YTVjMWE5NDI4MTlmNmU3NDY4YjA1OWFjNWRfNQ_16f36e97-56e1-43c0-8d7c-3c61149161d7">2450 Holcombe Blvd.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8zLTAtMS0xLTIxOTQ2L3RleHRyZWdpb246OGYzMTc1YTVjMWE5NDI4MTlmNmU3NDY4YjA1OWFjNWRfOA_2b1c85fe-ff75-41e9-8315-b72dfade506c">Suite X</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8zLTAtMS0xLTIxOTQ2L3RleHRyZWdpb246OGYzMTc1YTVjMWE5NDI4MTlmNmU3NDY4YjA1OWFjNWRfMTE_a7637e8d-bb55-4b76-8e27-4cb1dc9134c8">Houston</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8zLTAtMS0xLTIxOTQ2L3RleHRyZWdpb246OGYzMTc1YTVjMWE5NDI4MTlmNmU3NDY4YjA1OWFjNWRfMTU_59f14441-dc45-4059-a4c6-11cea178942d">TX</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8zLTQtMS0xLTIxOTQ2_c516a4b0-9704-4e12-8e1d-6969ecfe47ed">77021</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Zip Code)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGV4dHJlZ2lvbjpkNGExNTZkYzRmMzM0ZjViOWEzZThiMjczY2QzYmViZl8yMjM1_5945eb69-a2d2-45ca-8731-63d361a91dbb">832</ix:nonNumeric>) <ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGV4dHJlZ2lvbjpkNGExNTZkYzRmMzM0ZjViOWEzZThiMjczY2QzYmViZl8yMjM2_dc1429e6-b98e-4967-8996-224041e1a7d7">834-6992</ix:nonNumeric><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A <br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6MmMxMmMzOTEwM2I2NDJjN2EzNDlkNzMwYmQ0NmRhNjMvdGFibGVyYW5nZToyYzEyYzM5MTAzYjY0MmM3YTM0OWQ3MzBiZDQ2ZGE2M18wLTAtMS0xLTIxOTQ2_825e9974-0a4f-45c9-8adc-61babd1cc37b">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6MmMxMmMzOTEwM2I2NDJjN2EzNDlkNzMwYmQ0NmRhNjMvdGFibGVyYW5nZToyYzEyYzM5MTAzYjY0MmM3YTM0OWQ3MzBiZDQ2ZGE2M18xLTAtMS0xLTIxOTQ2_0f34fe3f-f762-4530-b77d-9945c6195ba0">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6MmMxMmMzOTEwM2I2NDJjN2EzNDlkNzMwYmQ0NmRhNjMvdGFibGVyYW5nZToyYzEyYzM5MTAzYjY0MmM3YTM0OWQ3MzBiZDQ2ZGE2M18yLTAtMS0xLTIxOTQ2_5059f7b3-5644-46c6-8177-2dd57cb0b635">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6MmMxMmMzOTEwM2I2NDJjN2EzNDlkNzMwYmQ0NmRhNjMvdGFibGVyYW5nZToyYzEyYzM5MTAzYjY0MmM3YTM0OWQ3MzBiZDQ2ZGE2M18zLTAtMS0xLTIxOTQ2_6fee2973-4d09-4f2c-99f4-70f4f9e547b5">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act:</span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Title of each class</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Trading Symbol(s)</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Name of each exchange on which registered</span></div><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NWM1ODhjNmJjZWMzNGExOTlmMDRkMWRmNWFhYjE0Y2QvdGFibGVyYW5nZTo1YzU4OGM2YmNlYzM0YTE5OWYwNGQxZGY1YWFiMTRjZF8xLTAtMS0xLTIxOTQ2_976b7b58-c252-4d10-8c1d-3a416dcf510d">Common Stock, par value $0.0001</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NWM1ODhjNmJjZWMzNGExOTlmMDRkMWRmNWFhYjE0Y2QvdGFibGVyYW5nZTo1YzU4OGM2YmNlYzM0YTE5OWYwNGQxZGY1YWFiMTRjZF8xLTItMS0xLTIxOTQ2_0442f2cd-6aa2-4cd2-8da5-ab3afca90af2">SLRX</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Nasdaq Capital Market</span></div></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Emerging growth company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGV4dHJlZ2lvbjpkNGExNTZkYzRmMzM0ZjViOWEzZThiMjczY2QzYmViZl8yMjM3_59b28f62-4eba-43ac-ab19-11020c744a44">&#9744;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9744;</span></div><div style="height:78.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:10pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 2.02&#160;&#160;&#160;&#160;    Results of Operations and Financial Condition. </span></div><div style="margin-bottom:0.1pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">On May 12, 2022, Salarius Pharmaceuticals, Inc. (the &#8220;Company&#8221;) reported financial results for the three months ended March 31, 2022 and other recent corporate updates. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The information in this Item 2.02 of this Current Report on 8-K (including Exhibit 99.1 hereto) is furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information shall not be deemed incorporated by reference into any other filing with the Securities and Exchange Commission made by the Company, whether made before or after today&#8217;s date, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific references in such filing.</span></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.000%"><tr><td style="width:1.0%"></td><td style="width:8.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.01</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Exhibits.</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="salarius-earningsrelease1q.htm">Press Release Announcing Financial Results, dated May 12, 2022.</a></span></div></td></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:78.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div></div><div id="i5b76934489b84ce5aa82a6cc52281968_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:133%">SIGNATURES</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Date: May 12, 2022</span></div><div style="margin-bottom:0.1pt"><span><br/></span></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.888%"><tr><td style="width:1.0%"></td><td style="width:33.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.407%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:49.5pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SALARIUS PHARMACEUTICALS, INC.</span></div><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Mark J. Rosenblum</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark J. Rosenblum</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>salarius-earningsrelease1q.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i481aa034c5f8412aa6bb6e44245f8dde_1"></div><div style="min-height:120.96pt;width:100%"><div><font><br></font></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:84px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Salarius Pharmaceuticals Reports Business Highlights with First Quarter 2022 Financial Results </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Salarius Successfully Completes SP-3164 Pre-IND Meeting Process with FDA </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Advancing multiple drug development programs, led by SP-3164 in targeted protein degradation, and seclidemstat in protein inhibition, a clinical-stage reversible LSD1 inhibitor </font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Multiple potential development and data milestones expected from both programs in 2H 2022</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">2022 Annual Meeting of Stockholders announced for June 15, 2022&#59; Company is encouraging all stockholders to participate and vote their shares of Salarius Pharmaceuticals stock.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Conference Call and Live Audio Webcast Scheduled for Today, May 12, 2022, 5&#58;00 p.m. ET</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">HOUSTON, May 12, 2022 (GLOBE NEWSWIRE) &#8211; Salarius Pharmaceuticals, Inc. (Nasdaq&#58; SLRX), a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options, today reported important corporate events and its financial results for the first quarter ended March 31, 2022.</font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;We have high expectations for 2022 as we build on the progress achieved during the first quarter and recent weeks,&#8221; stated David Arthur, CEO of Salarius Pharmaceuticals. &#8220;Recent highlights include our acquisition of an intellectual property portfolio, including the drug candidate SP-3164, which is now the foundation of our new drug development program focused on targeted protein degradation (TPD), and the subsequent completion of SP-3164&#8217;s pre-IND meeting process with the FDA. TPD is a fast-growing field of cancer drug research with significant potential to improve patient&#8217;s lives and a market potential estimated in the billions of dollars.  Coupled with our existing clinical programs for seclidemstat, our most advanced cancer drug candidate, Salarius is now pursuing multiple drug development programs built around two exciting approaches to cancer drug development &#8211; protein inhibition and protein degradation.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Financial Highlights</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:125%">&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:13.8pt">Cash and cash equivalents totaled $24.2 million on March 31, 2022&#59; $2.3 million direct offering with institutional investors closed on April 26, 2022&#59; Estimated cash runway extends into 2023. </font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:13.8pt">For the three-month period ended March 31, 2022, net loss per common share, basic and diluted, of $0.13, compared to $0.06 for the same period in 2021</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Recent Business and Corporate Highlights&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:13.8pt">2022 Annual Meeting of Stockholders announced for June 15, 2022&#59; Company is seeking stockholder approval or authorization of four proposals and is encouraging stockholders to participate and vote their shares of Salarius Pharmaceuticals stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:120.96pt;width:100%"><div><font><br></font></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:84px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:13.8pt">Advancing new TPD cancer drug development program built around an intellectual property portfolio acquired from DeuteRx LLC in January 2022.  The lead development candidate is SP-3164 for which the company has&#58;</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:125%">&#9702;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:10.8pt">Completed the FDA Pre-IND meeting process, which has informed planned IND-enabling studies and activities&#59; and</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:125%">&#9702;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:10.8pt">Initiated preclinical studies to support the potential submission of an Investigational New Drug (IND) application with initial preclinical data anticipated in the second half of 2022 and potential for first clinical trial in 2023.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:14.15pt">Salarius continues its enrollment activities to advance clinical exploration of seclidemstat in the treatment of sarcomas, while MD Anderson Cancer Center is enrolling patients in the investigator-initiated trial exploring seclidemstat as a treatment for hematologic cancers.</font></div><div style="margin-bottom:8pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:11pt;font-weight:400;line-height:125%">&#9702;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:11.4pt">Data updates expected in 2022 from both ongoing Phase 1&#47;2 clinical trials.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#8220;As both CEO and a stockholder of Salarius, I am excited about the upcoming value-building opportunities we expect to achieve&#8221; continued Mr. Arthur.  &#8220;On June 15, the Company will hold its Annual Meeting of Stockholders, where Salarius is asking stockholders to vote on several proposals that we believe will augment these opportunities. All stockholders are encouraged to vote their shares through their brokerage website or through the proxy materials.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> &#8220;We believe the combination of multiple drug development programs built around two exciting approaches to cancer drug development &#8211; protein inhibition and protein degradation &#8211; coupled with upcoming value-building opportunities will benefit both current and future stockholders&#8221; concluded Mr. Arthur.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Three-Month Financial Results&#58;</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">For the three-month period ended March 31, 2022, Salarius&#8217; reported net loss was $6.1 million, or $0.13 per basic and diluted share, compared to a net loss of $1.9 million, or $0.06 per basic and diluted share for the same period in 2021. The loss for the three-month period ended March 31, 2022, increased by $4.2 million compared to the same time span last year, primarily because the Company had higher research and development costs and no grant revenue in the current period.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Net cash used for operating activities during the three-month period ended March 31, 2022, totaled $3.5 million, compared to $2.7 million during the same span last year. </font></div><div style="margin-bottom:8pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">As of March 31, 2022, total cash, cash equivalents, and restricted cash were $24.2 million, compared to $36.6 million as of March 31, 2021. The decrease in cash was primarily driven by the Company&#8217;s continued spend on operating activities, especially research and development activities and less financing activities involved since Q1 2021. Current cash and cash equivalents are expected to fund our current planned operations into 2023. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:120.96pt;width:100%"><div><font><br></font></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:84px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Conference Call Information&#58;</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Salarius Pharmaceuticals will host a conference call and live audio webcast on Thursday, May 12, 2022, at 5&#58;00 p.m. ET, to discuss its corporate and financial results for the first quarter 2021. Interested participants and investors may access the conference call by dialing either&#58;</font></div><div style="margin-bottom:8pt;padding-left:72pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(833) 423-0481 (U.S.)</font></div><div style="margin-bottom:8pt;padding-left:72pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(918) 922-2375 (International)</font></div><div style="margin-bottom:8pt;padding-left:72pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Conference ID&#58; 8798303</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">An audio webcast will be accessible via the Investors Events and Presentations section of the Company&#8217;s website http&#58;&#47;&#47;investors.salariuspharma.com&#47;. An archive of the webcast will remain available for 90 days beginning at approximately 6&#58;00 p.m. ET on May 12, 2022.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">About&#160;Salarius Pharmaceuticals</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options. Salarius&#8217; product portfolio includes seclidemstat, which is being studied as a potential treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options, and SP-3164, an oral small molecule protein degrader. Seclidemstat is currently in a Phase 1&#47;2 clinical trial for relapsed&#47;refractory Ewing sarcoma and select additional sarcomas that share a similar biology to Ewing sarcoma, also referred to as Ewing-related or FET-rearranged sarcomas. Seclidemstat has received Fast Track Designation, Orphan Drug Designation, and Rare Pediatric Disease Designation for Ewing sarcoma from the U.S. Food and Drug Administration. Salarius has received financial support from the National Pediatric Cancer Foundation to advance the Ewing sarcoma clinical program and was also a recipient of a Product Development Award from the Cancer Prevention and Research Institute of Texas (CPRIT). For more information, please visit </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">salariuspharma.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%"> or follow Salarius on Twitter and LinkedIn.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Forward-Looking Statements</font></div><div style="margin-bottom:26.25pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This press release contains information that includes or is based upon &#8220;forward-looking statements&#8221; within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements provide our expectations or forecasts regarding future events. You can identify these statements by the fact they do not relate strictly to historical or current facts. They may use words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;indicate,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;underway,&#8221; &#8220;will,&#8221; and other terms of similar meaning in connection with a discussion of future operating or financial performance. In particular, forward-looking statements include statements relating to intended future actions&#59; the potential size of the commercial market for our drug candidates&#59; the focus of our drug development programs&#59; whether we will realize or achieve any value-building opportunities or other benefits to stockholders&#59; the functionality and capabilities of our drug candidates&#59; our ability to expand our pipeline into new areas of drug research&#59; the continuation or advancement of new and existing clinical trials&#59; timing of updates from our clinical trials and other activities&#59; plans to file INDs or other regulatory filings&#59; and ability of cash and cash equivalents to fund our operations into the future. Any or all of our </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:120.96pt;width:100%"><div><font><br></font></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:84px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"></div></div><div style="margin-bottom:26.25pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">forward-looking statements here and elsewhere may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements and from expected or historical results. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed. In particular, you should read those risks described under the heading &#8220;Risk Factors&#8221; in our Securities and Exchange Commission filings, including in our annual and quarterly reports. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law. These forward-looking statements (except as may be otherwise noted) speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You are advised to consult any further disclosures we make on related subjects in our reports to the SEC.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Contacts</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Tiberend Strategic Advisors, Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Investor Relations</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Jason Rando&#47;Daniel Kontoh-Boateng</font></div><div><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">jrando&#64;tiberend.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%"> </font></div><div style="margin-bottom:8pt"><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">dboateng&#64;tiberend.com</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Media Relations</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Bill Borden</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br></font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">bborden&#64;tiberend.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SALARIUS PHARMACEUTICALS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CONSOLIDATED BALANCE SHEETS</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:120.96pt;width:100%"><div><font><br></font></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:84px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">3&#47;31&#47;2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">12&#47;31&#47;2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(Unaudited)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Assets</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;24,193,554</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;29,214,380</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">662,854</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">949,215</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total current assets</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24,856,408</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">30,163,595</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Grants receivable from CPRIT</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,610,490</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,610,490</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Property and equipment, net</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,190</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,880</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other assets</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">170,907</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">185,994</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Goodwill</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,865,909</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,865,909</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total assets</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;35,507,904</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;40,833,868</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Liabilities and stockholders' equity</font></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accounts payable</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;1,693,398</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;1,543,096</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accrued expenses and other current liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">390,233</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">553,269</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Warrant liability</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,710</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">14,518</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,092,341</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,110,883</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Commitments and contingencies (Note 5)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stockholders' equity&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.02pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Preferred stock, $0.0001 par value&#59; 10,000,000 shares authorized&#59; 0 issued and outstanding</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Common stock, $0.0001 par value&#59; 100,000,000 shares authorized&#59; 46,697,194 and 45,241,808 shares issued and outstanding on March&#160;31, 2022 and December&#160;31, 2021, respectively</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,669</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,524</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Additional paid-in capital</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">71,717,311</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">70,915,653</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accumulated deficit</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(38,306,417)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(32,197,192)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total stockholders' equity</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">33,415,563</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">38,722,985</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities and stockholders' equity</font></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;35,507,904</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;40,833,868</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:120.96pt;width:100%"><div><font><br></font></div><div><img alt="image_0.jpg" src="image_0.jpg" style="height:84px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SALARIUS PHARMACEUTICALS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:0.08pt;padding-left:55.12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.442%"><tr><td style="width:1.0%"></td><td style="width:53.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.686%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:3.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Three Months Ended</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">March 31</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2022</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2021</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Revenue&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Grant revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$&#160;&#160;&#160;&#160;1,268,829</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Research and development</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,439,475</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,740,655</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">General and administrative</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,677,754</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,332,769</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total operating expenses</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6,117,229</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,073,424</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss before other income (expense)</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(6,117,229)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,804,595)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Change in fair value of warrant liability</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5,808</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(46,054)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Interest income (expense), net</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,196</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,247)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss from continuing operations</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(6,109,225)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(1,851,896)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">$&#160;&#160;&#160;&#160;(6,109,225)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">$&#160;&#160;&#160;&#160;(1,851,896)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Loss per common share&#160;&#8212; basic and diluted</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">$&#160;&#160;&#160;&#160;(0.13)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">$&#160;&#160;&#160;&#160;(0.06)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:0.75pt;padding-left:4.5pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Weighted-average number of common shares outstanding&#160;&#8212; basic and diluted</font></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">46,255,210</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">30,551,316</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%"> </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>flks-20220512.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b39be0aa-e8b5-4363-a343-a7c7e78eeb90,g:25e805b9-63b1-4011-a802-8e989fd7d5b7-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:flks="http://www.flex-pharma.com/20220512" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.flex-pharma.com/20220512">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="flks-20220512_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="flks-20220512_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.flex-pharma.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>flks-20220512_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b39be0aa-e8b5-4363-a343-a7c7e78eeb90,g:25e805b9-63b1-4011-a802-8e989fd7d5b7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityAddressAddressLine1_6c809020-a362-47b6-9570-4c50b7d23fea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_23db0e87-1329-48b9-93b7-9976d178e49d_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_03c4d7da-bc66-4a68-a6a1-9af7c2a8af20_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b717000a-d237-42eb-9a86-95efd2d1db4b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1ee9e17a-bbfc-4247-a7c7-71f866485a24_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_0ecf6eb9-41b1-4215-be20-6df7c64bd599_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_0bcc37d0-5ec5-49ed-a9ac-e4fa201ac5c8_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_20ea3137-2d61-43ae-a4c3-2d8e93e1c906_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2e14032c-1da5-44c8-ac21-89a0267e3df5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_372eeb34-a843-430c-b009-19f23031e6b6_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e11bca24-b0fa-4eb8-8a5b-043239a199e1_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6c827cff-2831-4f21-b727-b1f590b5e31b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1c034b8b-bec3-4503-a7a4-64be13d96839_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4d8321b1-3f32-47d8-b6d6-3532253e1de6_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_8c83a23a-ab9f-4120-902a-d6288648f329_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_929fe019-7258-4308-86f4-7bdae6dc63c7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_08386195-6134-4d45-9a7f-7edb2aec6d0e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f7762f92-1261-4bd2-bd65-7bd924c0b845_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1086392f-2c37-4a23-98a9-be7836fd9c0b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8179a5fd-12c2-4dce-9d33-50e156072193_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_cf605c22-f46f-4fb2-a9d5-704c3484961a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2a561104-e2c0-477b-b8d6-a216ec18e8ef_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>flks-20220512_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b39be0aa-e8b5-4363-a343-a7c7e78eeb90,g:25e805b9-63b1-4011-a802-8e989fd7d5b7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CoverPage" xlink:type="simple" xlink:href="flks-20220512.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.flex-pharma.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6daa6e8d-2e95-4061-869a-fcea7d775bbf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_DocumentType_6daa6e8d-2e95-4061-869a-fcea7d775bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e4930f95-8f88-4226-bde8-6a65ab545771" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_DocumentPeriodEndDate_e4930f95-8f88-4226-bde8-6a65ab545771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8f719393-c75c-4da8-b6c5-52491ebd088c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_EntityRegistrantName_8f719393-c75c-4da8-b6c5-52491ebd088c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_aefd23ab-6bf1-44ec-8d2d-2479a502aac0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_EntityIncorporationStateCountryCode_aefd23ab-6bf1-44ec-8d2d-2479a502aac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5493a95c-e40a-4925-bc2f-59c8f0847c3e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_EntityFileNumber_5493a95c-e40a-4925-bc2f-59c8f0847c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d16f406d-6258-4249-8f45-1c551b477bf8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_EntityTaxIdentificationNumber_d16f406d-6258-4249-8f45-1c551b477bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_c476d596-1328-4a67-abae-dc3f82f4f47a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_EntityAddressAddressLine2_c476d596-1328-4a67-abae-dc3f82f4f47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_cfa709a3-21d6-433a-9a24-b9dd70263429" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_EntityAddressAddressLine1_cfa709a3-21d6-433a-9a24-b9dd70263429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_24d0c1c5-5a34-4bd6-85af-d6f1f6fb4dd3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_EntityAddressCityOrTown_24d0c1c5-5a34-4bd6-85af-d6f1f6fb4dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2c3ec610-a772-4601-ba05-782fcd1e7422" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_EntityAddressStateOrProvince_2c3ec610-a772-4601-ba05-782fcd1e7422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_30939502-d983-484e-a24a-70f4e8941a71" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_EntityAddressPostalZipCode_30939502-d983-484e-a24a-70f4e8941a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6f03818e-f770-45c6-ac2a-4ac13ca328a9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_CityAreaCode_6f03818e-f770-45c6-ac2a-4ac13ca328a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_008644a4-7a81-460f-8ae2-892f2cfcbccd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_LocalPhoneNumber_008644a4-7a81-460f-8ae2-892f2cfcbccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_7efc13d1-9b29-4f62-aec6-7e142d5ec7b0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_WrittenCommunications_7efc13d1-9b29-4f62-aec6-7e142d5ec7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_09ca00d8-33b5-4fd3-8886-31b69379633f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_SolicitingMaterial_09ca00d8-33b5-4fd3-8886-31b69379633f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_32d5503b-0ff0-4041-baf9-7fb6a083c7c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_PreCommencementTenderOffer_32d5503b-0ff0-4041-baf9-7fb6a083c7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_e097c8a4-5816-49be-a897-f00169bf2f62" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_e097c8a4-5816-49be-a897-f00169bf2f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f1df57d9-dbbe-4ec7-a20c-1b4ae59e3498" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_Security12bTitle_f1df57d9-dbbe-4ec7-a20c-1b4ae59e3498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_79a5bdeb-6661-42a4-a7d1-3e29c92240b4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_TradingSymbol_79a5bdeb-6661-42a4-a7d1-3e29c92240b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_57cb2d12-fa57-469b-ac99-33fa99e6b752" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_EntityEmergingGrowthCompany_57cb2d12-fa57-469b-ac99-33fa99e6b752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_80d102b7-b686-4e7c-a15a-06bf7dc21465" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_EntityCentralIndexKey_80d102b7-b686-4e7c-a15a-06bf7dc21465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c5ab3052-f1d8-4b4a-b8e1-6b8c20261ce1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5dfd8494-555f-4f6c-8cac-661ec9dd2459" xlink:to="loc_dei_AmendmentFlag_c5ab3052-f1d8-4b4a-b8e1-6b8c20261ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X2MV17AI9@  34T *@    @ "0 +  (
M   F   (A@$2  ,    !  $   $:  4    !   (K $;  4    !   (M $H
M  ,    !  (   $Q  (    F   (O $R  (    4   (XH=I  0    !   (
M]NH<  <   @,    >@  $3H<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M         %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P,3$N,38S.#0
M "W&P   )Q  +<;    G$%=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 ,C R,CHP,3HR." Q,SHU-#HQ-   !* !  ,    !  $  * "
M  0    !   &O: #  0    !   "[NH<  <   @,   )+      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                          8! P #     0 &   !
M&@ %     0  $8@!&P %     0  $9 !*  #     0 "   " 0 $     0
M$9@" @ $     0  &=4         8     $   !@     ?_8_]L 0P (!@8'
M!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N)R B+",<'"@W*2PP
M,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<(3(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R_\  $0@
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M 0 "$0,1 #\ ]_HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
M"B@ HH SKK48[76K"SD8*;M9 F>[* <?EG\JT:;5K"$)"J68@ <DGM45O>6U
MV&-M<13;3AO+<-C\J+,9-12 ** "B@ HH ** "B@ HH ** "B@ HH ** "B@
M HH ** /,/C'=W.F1:#J=JQ66VNRRM[X!_I7;^&/$5IXHT.#4K0XW#$D9/,;
M]U-=$H7HQD0G[S1PGQKUVYL-(L=+MG:-;UG:9E."57'R_0EOTKRSP/K=UH?B
MW3YK>5E2698I4!X=&(!!'?KG\*ZZ$$Z'J93?OGU-1G R:\PZ#B]4^*?A72[I
M[9KU[B1#AOL\9< _7H?PJYH/Q!\.>([D6ME>[;EONPS+L9OIG@_05N\/44>:
MQ'/&]CJ**P+"N>7QMH;^)O\ A'A<2?VCO,>SRSC(&>O3I51@Y7MT$VD=#14C
M"B@ KFM/\=Z)J?B230;9YS?1NZ,&B(7*9W<_A5Q@Y)M=!-I'2T5 PHH ** "
MB@ HH ** "B@#D_B/H#>(?!EW!$NZY@Q<0CU9>H_$9'Y5X+X/\7WWA#5?M-O
MF2W?Y9[<G <?T([&O0PR52DX,PJ:23/7/%NFV?Q1\(V^H:#,DEW:L61&.T\@
M;HV]#P/R]ZY#P-\,-;/B.WO-8M3:6EI()2'(+2,#D  >_>E"LJ=-PENAN/-)
M-'MD-^D^KW5FAS]GC0N?]IB>/R _.N9^*=_<Z?X"O7M79'E9(F93@A6//^'X
MUS1A:I%/R"-3G@VO-?<['$_"CPKX8UO1I[C4(8KS4%E*M#(Y_=IQ@[0>_K6]
MJ7P<TR;6;>]TF\ETR)#N>./+D,#P4)/R_K71/$3A4:>P*"<4=_?ZC::/IKWF
MH7*Q6\*C?*_'^2?05PTGQJ\+).8UBU&10<>8L*[?U8']*YZ="=17B7*:CN=A
MH/B32O$MF;K2[D3(IPZD$,A]"#TKQ^W_ .3A3_U^/_Z*-:48N+FGV8I.]FCV
MO4=2L])L);V_N$@MHAEG<\#_ .O7"2_&KPM'.8UBU&1<X\Q85V_JP/Z5G2H3
MJ*Z*E-1W.OT#Q)I7B:S:YTNZ$R*<.I!#(?<&LS_A8.@KXBFT22:6*Z@W^8\B
M8C78I8G=GT%)49MM=@YE:Y#I'Q)T'7?$*:-I_P!JEE<,5F\L",X&3R3G]*PO
M#S>"C\2+D:<E\-<\V?S#)GR]W._'/UQ6BIU*=UY:D\T78Z;4/'>C:;XECT"X
M-Q]ND9%7;'E<MTYS[UMZIJ5OI&EW.H76[R+=#(^P9.!Z"LG3DK>9:DBCX;\3
MZ=XJL)+S33*8HY/*;S4VG. ?ZUAZ[\4_#6@WCVDDMQ=SQG:ZVJ!@I]"20/RJ
MHT)RFX+H)S25R?P[\2?#OB6[6TM9Y8+I_N0W*!"WT()!/MFNNJ*E.5-VD.,E
M)7045 PHH ** "B@ KP;XI> 'TJ\EUW3(<Z?,VZ>-!_J6/?_ '3^E=.%J<L[
M/J9U%='#^'?$NI>%]26]TZ8J<CS(FY24>C#_ ":]WTWXGZ3J?AR2_C^2^C^5
MK-NN\],'NOO776PSJS3B<U3$*A2E.71#/AW<S7EYJ]S.Y>60HS,>Y^:NQU72
M[36M,GTZ^B\RWG7:ZYP?J/0BN?&^YB'R]+?DC'*9.>#BY=;_ )L\>U#X*:K9
MSM/H>KQ/M.4$I,;C_@2Y&?RK(C\5>./ 6KPP:R]Q+">3!<L)%D7N5?GGZ'ZU
MM&I3Q"Y9+4['&4-4>H^,H-!\2>#K6[U35)+'3'V7*2(0"V5^48(.3ST%<9;^
M-?AM8:2NEKHT]S$D8C,S6<9:0XQN)+ Y/7M6%*%64>6.EF5)Q3NRE\$9?^*H
MU:*(L(&M=P4^SC&??!--M_\ DX4_]?;_ /HHUM+^)/T)7PKU/2_B!IFCZGX=
MV:YJ4EA912B0R(1EC@X&"#GKT KA+;QI\-M/TM-+71I[F*.,1M,UG&6EXP6)
M+ Y/7M6-*-6<+0T2+DXIW91^"4O_ !56JQQ%A UJ6"GV<8S[X)K(U#11XA^,
M]UI32-''<7C[V7KM52S8_ &NB_+5D_(SWBD>WZ5X1T#1)(Y=/TN"&:,864#+
M],'D\UY'X+_Y+C??]?%W_P"S5STIRDIN78N22:L/\8?\ESLO^NUM_(5ZCX]_
MY$+6_P#KU>G4WI_((_:.0^"RN_@O4EC.'-VX4^AV+7GWA[5E\"Z[>IX@\/B\
MG?Y?WX&Y""<E=P(.<]?:M8KFG.*=FR7HDST/PKXE^'^K>(DN+;3$T[5I,+'Y
MT0"L?]G!*@^_!KU"N2O&<96F:P::T"BL2@HH ** "B@ ILD:2Q-'(BO&X*LK
M#((/4&@#POX@_#6UTJ[2]TJYBAMYWPUJ[?,A[E?5?;M659V<-C (HEP.Y[L?
M4U]'@+SI\\CY//<1:2P\?5_HCTGX7WNGRPZE;13@WR2+YL9[)C@CUY)J]\2H
M_$G_  CZW'ARYFC>(DW$< _>.A[J>N1[>OM7E8AIXMN>USW,NING@X17;\]3
MB?#OQG>PTY++7;&>XGA&P3QL-S ?W@>_O6'XH\0WWQ1UNPL=)TN1(X20F3N.
M6ZLQ'"@ 5I'#JG/VE]#I<^9<IT7Q:T2ZT[P=X=MK??+9Z>ODS,!WVJ%8^G1O
MSI-/^('@BTT&"WA\.;KQ8@GDBU0[GQ_>ZG)[]:B,95*2Y';5W&VHRU,_X*,?
M^$QU0.NQS:,2F,8_>+D8JEKNH?\ "+_&J;5+V"0PQS^;A1RRLF,C/7K^E:-7
MK2CW1.T4S9^*6HR>*/!NBZWI\4PT\32^:K#E3P%)Q]&_.GZ;\0?!%GH-O;Q>
M' UXD07R1:H=[X_O=3D]^M0J4Y4U&+V;N4Y)2NRA\%&)\9:H'38YM&)3&,?O
M%R,4[2?^3AW_ .OF?_T2]5/XY^@ELO4]SKPCP7_R7&^_Z^+O_P!FKFH?#/T+
MGNA_Q6MKO1/']CXACB+PL(W5B/EWH>5)^@'YU;\4_%*+Q+X8NM+TG3+L3SQ9
MG9P"(HQRQX]AUXKHC3]I&$[[$.7*VC5^#4SV_@?5)HX7G>.Z=EB3&YR(UX&>
MYJO;?%W2KL7%GXIT1H]LC;8_*$@"]@RMW'?^E9RHNI4DXO5%*5HJYQEU%9>+
MO']F/".E/9VX:/?M3:%(8DR$#A1C'Y>]?1]3BKKEBWJAT^K045R&@44 %% !
M10 5D>(?$%OH%CYTOSS/D11 \L?\*THTW5FH+J88FO&A2E5ET/'M2U*ZU:]>
MZNY"\C=!V4>@'84D>DW%[I]R\4PMY1'F'?$["1O0$#COS7U$K4:=H]#X.E_M
M&(YJKW=V<QX:N]2\)^+["[E5HF,PCF1CRR,<,"/H<_7%?4'45X..C:29]UA:
MD:D+QV,Z[T#1M0D\R]TFPN7_ +TULCG\R*LVEA9Z?'Y=E:06T?\ =AC"#\A7
M&YR:LWH=%D3.B2HR2(KHPP589!JA;^']%M+C[1;:1I\$W7S(K9%;\P,TE)I6
M3"R+$&GV5M,TUO9V\4K AGCB56.>3D@4V\TO3]1*F^L+6YV?=\^%7Q],BCF=
M[W"R)DM;>.V^S)!$L &/*5 %QZ8Z53M_#^BVEQ]HMM'T^&<'/F1VR*WY@9IJ
M4ELPLBQ#I]E;3M/!9V\4K9#21Q*K'/)R0*%TZQ6[^UK9VXN<D^<(EWY/!YQF
MES/N%D6:K1Z=8PW)N8K*W2<DDRK$H8YZ\XS0FT,DN+:WO(6AN8(IXFZI*@93
M^!JM;:+I5E%)%:Z9901R#$B10*H<>X YH4FE9,5D6+:TMK.,QVMO% A.2L2!
M03Z\56O=#TG4GWWVEV5TW]Z>W5S^HIJ4D[IA9$UGI]EI\7EV5I;VT?\ =AB"
M#\@*LTFVW=C"BD 44 %% !10 R65887E<X1%+,?85XAK>K3:UJDMY*< G$:=
ME7L*];*J=Y2GV/G.(:S5.%)==?N-G0/!^H7@AOY;6)[8G(BFD*;QV/ /%>@)
M)KD4:QQZ=IZHHPJK<L !_P!\48VM1JSY7)Z>7_!'E6%Q.'I<\8*\N[L[?<<#
M\3-(>>*QU>_MK*UNHKB.-7BF+/-EA\N-HSCKGMS7?ZM-=K/IEM:W)M_M$K*[
MA%8X"$]Q[5S/D?*EJE??0]1RKJG)RM%W6VN[2ZHC6XO].UFSL[F[%Y#=AP&,
M81T*C/;@BK4-W,_B.ZM"_P"XCMHY%7 X8E@>?P%9RA!KF2MI?\;!"I43Y).[
M4K7[JUQIO)QXH6RW_P"CFT\W;@?>W8SGKTHURZNH;6*"P=4O+B01Q,P!V]R<
M?0&I4(\\;[;LJ56?LYM/6]E^A9TN\^WZ9;W)X9T^<>C#@C\"#63:G5-1OM2"
M:J]O';W)B1%@1AC:#U(SWIQC&+ES*]O\Q5)U*D:?LY<O-Y)]+]2]I-[<7-I<
MK<%#-;3/"SH,!]O?';KTK/\ "VM7.H0R0Z@ZFY4>:C  ;XR<9X]",'\*ITH\
MLVNEK$1Q,^>DI;23OZJW]?,71=8N]2UV\5\"Q\O?;+@9(#%=V>O)!JUK]Y>0
M00V^FD"]G<["1G"J-S''X8_&G*E"-90>W7[M10Q%6>&E47Q-NWS=E^A?TZ\3
M4-.M[N/[LJ!L>A[C\#61:2:GK:2W<.H&RMQ*\<,<<2L2%)&6+ ]P>!41C&#D
MYJ]M/Z^XUJ5)U5"-.7+S*]]]-/\ ,NVES>G2KAKN/9<P[UW!<!\=& ]#6?I4
M.KZCI-K>/KDB--&'*BVCP,_A5)4H*3M?734S;KU)0BI<KLV]%OIW+^JW5Q9K
MIRQR<RW4<4C%1\RGK]*=KEW-9:;YT#;7\V-<X!X+@'K[&HC"+</-FM2K.*J6
M>RT^XGO;:[N"GV:_>UQG<%B5]W_?0K)\.MJ=_96]]<ZH[JQ;=#Y* '!(Z@9I
MQ=/V3;CKZOK<F<:WUA)3LG=VLNEOSN7H;R=_$EU9L_[B.W1U7 X))SS^%51-
M?ZMJ-Y%;7IL[>TD$64C5GD; )^\" .::C"+YFKI)?C84JE2:4(NS<FK]DKES
M2Y+_ ,RZMK\;S"X$=P$VB52,YQZCH<5GZOK5S::M$L&#:6VQKWC/$C;5^F.3
M3A3A.JTMO\_\FQ5:]6G04G\5_P GK]Z3-J\D:*QN)8SAEB9E/N!Q46DSR76D
M6<\S;I)(E9CC&216/*O9W\SIYW[51Z6_4IZY?S6LMC;17"6HNI2C7#J#LP"<
M#/&3TYJ>RMM1M[DB>^6[M67@N@616_X",$5I:$::NM7U,4ZLZ[Y9:1:T\K7O
MW]/0?K7_ " [[_K@_P#(UY5X8TK3KZ=YM5NT@MX^%7?M9S_@*[L#.4*$W!79
MY.;4H5<72C4=HZW.[#Z(  -?N0!T'VHU#>:AX>L;62XN/$=RL:#)_P!*))]@
M.YK"U?\ Y]K[CLC]5;LJS_\  CQ?4-=O/&?C*PMH'N3:?:D6VAFDWE02,L??
M^5>\Z[;"YO\ 1H2\B*9WRT;;6'[MN]75]V<?)/\ (WG#]RXW>Z]=T7K31[6T
MN/M(,LL^W:))I"[ >@ST_"LN73;34/%MT+NW654M(MN[M\S5S0K3O*>SM^J"
MKAJ:C&FU=.6M^NC"UT^VT_QB$M(%BC:QR0O0G?2SPWNI>(Y9K2XCA2Q3R5+Q
M[P7;EL<CH-HK3GO+GGK[O_ ,52:A[*EI[WY:_H/T*.?3M1OM-N9%D+'[5&RK
MM!#<, .V#_.J,&DO?S:\8KFXMY_M;",I*RKG:O4#K3511G*:6C2_0ET93IPI
M-ZIR5UIT=C6T-X6T<QQ6WV:2(LDT.<E7[\]\]<]\UBVNARZGX;TV2VG-K<HK
MQM)CDQ,Q#+_A2C/V<I2EKK]^C*G2]O"$(>[[K^33B:UK;I;>)C#$NV*/3T11
MZ .:KF/4-2\075U:7$<$5HOV9#)%OW,<,Y'(_P!D?A24HW<YZZ?F7*$N54Z;
MM[S_  U_R)?#XEL;J^TJ=@SQOY\;*NU2K\G [8;/YBJVB:G::19RV&HS+:SP
MSR'$O&]2Q8%?4<TY1=1R4%J[/^OO)IU%14)5'9+FC?YJWWV-.WO)=0T:YN'@
M,2L)!$#G+(!PQ!Z9KG-#_P"$8CTFR>Y:V6Z6-2^XG(:G3C4C&4:7?_,FM.A.
M=.>(TNG:_JC=\0EC8V=Y$C2QV]S%.X09)0'D@=^#575=4LM7MX;+3YUN9I9X
MSB/G8H8$EO3@=ZFE!M1DMHO4TKU8QE.#WDE;SZ'25B>$P1X<M@1CE_\ T(UA
M'^%+U7ZG5+_>(^DOSB+;@_\ "87QQQ]DB_\ 0FJK9WMOH^K:I#J$JVXGG\^)
MY.%=2HZ'ID8Z5NHN=XQWLOT.5S5.U2>B4I?C<TM/U7[=]KG$>VRB;$4QS^\
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MJ\(72N4_[4N?^@/>_G'_ /%4?VG<_P#0'O?SC_\ BJ7L8_SK\?\ (Q^LU/\
MGU+\/\P_M.Y_Z ][^<?_ ,51_:=S_P! >]_./_XJCV,?YU^/^0?6:G_/J7X?
MYA_:=S_T![W\X_\ XJC^T[G_ * ][^<?_P 51[&/\Z_'_(/K-3_GU+\/\P_M
M.Y_Z ][^<?\ \51_:=S_ - >]_./_P"*H]C'^=?C_D'UFI_SZE^'^8?VG<_]
M >]_./\ ^*H_M.Y_Z ][^<?_ ,51[&/\Z_'_ "#ZS4_Y]2_#_,/[3N?^@/>_
MG'_\50=2N#UT:\/XQ_\ Q5'LH_SK\?\ (/K,_P#GU+\/\P_M.Y_Z ][^<?\
M\51_:=S_ - >\_./_P"*H]E'^=?C_D'UF?\ SZE^'^8?VG<_] >]_./_ .*H
M_M.X'31[S\X__BJ/91_G7X_Y!]9G_P ^I?A_F']J7/\ T![W\X__ (JC^T[G
M_H#WOYQ__%4>QC_.OQ_R#ZS4_P"?4OP_S#^T[G_H#WOYQ_\ Q5!U.X/71[P_
MC'_\51[*/\Z_'_(/K,_^?4OP_P P_M.Y_P"@/>_G'_\ %4?VG<_] >]_./\
M^*H]C'^=?C_D'UFI_P ^I?A_F']IW/\ T![W\X__ (JC^T[G_H#WGYQ__%4>
MRC_.OQ_R#ZS/_GU+\/\ ,/[3N?\ H#WOYQ__ !536MY-/+Y;Z=<6ZXSOD*8_
M0FE*G%*_,OQ_R*C7G*23IM?=_F7:SM=UJT\/Z-<:G>MB&%<X'5CV4>Y-913D
MTD=#=E<^7_$GB._\4:O)J%])DGB.,?=C7LH_SS7H?PY^%[7AAUK7X2MOP]O:
ML.9/1G'I[=_Y^K5FJ-.R.>*YI:GMH 4    < "EKR3I"B@ HH ** "B@ HH
M** "B@ HH ** "B@ HH ** "B@ KR3XZ7TD6FZ/8J2(YY9)']]@4#_T,UOAE
M>JB*GPLK_#+X:J4AU[7(<Y^>UM7'&.SL/Y#\:]CHQ-3GGY(*<;(**P+"B@ H
MH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ KCO%?AJ+Q'XM\-K=)OM+1
M;B>5>S8,6U3[$_H#6E*7+*_K^1,E=6.P    & .@%+69044 %% !10 44 %%
M !10 44 %% !10 44 %% !10 44 %% !3=HWA\?, 0#]?_U4 .HH ** "B@
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M<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '
M      IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN4')O
M;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2<')I
M;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O;VP
M     %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB
M;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L
M      !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!O
MX            $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M      !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M          !2<VQT56YT1B-0>&Q <L            IV96-T;W)$871A8F]O
M; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L
M=                %1O<"!5;G1&(U)L=                %-C;"!5;G1&
M(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P
M4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M#6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<
M #A"24T#[0      $ $L     0 ! 2P    !  $X0DE-!"8       X
M        /X   #A"24T$#0      !    '@X0DE-!!D       0    >.$))
M30/S       )           ! #A"24TG$       "@ !          $X0DE-
M _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $
M,@    $ 6@    8       $ -0    $ +0    8       $X0DE- _@
M '   /____________________________\#Z     #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z   .$))300        " !XX0DE-! (
M     $(
M                                   X0DE-!#       "$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$ .$))300M       &  $    O
M.$))300(       0     0   D    )      #A"24T$'@      !      X
M0DE-!!H      U\    &              +N   &O0   !4 4P!A &P 80!R
M &D =0!S $P ;P!G &\ 30!A ', = !E '( 4@!' $(    !
M              $             !KT   +N                      $
M                        $     $       !N=6QL     @    9B;W5N
M9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,
M969T;&]N9P          0G1O;6QO;F<   +N     %)G:'1L;VYG   &O0
M  9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2    !W-L
M:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU
M;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU
M;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M  !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M $)T;VUL;VYG   "[@    !29VAT;&]N9P  !KT    #=7)L5$585     $
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M0DE-!!0       0   !*.$))300,      OW     0   *    !&   !X
M@T    O; !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4 9(     !_]L
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MZJW]%^L/2\/H>#D#,S^F8F,^O-JZ7::KO7)W4[OTF/9=B5,/I4[+&?S6]_\
M@ZU4_P";77;?J]]:</[#=5?G74VXE5UK;GO8US+7 Y7J6>M<UC/?NL_G/T>]
M-C& ()(^8:_X?[K*27LNI=?;TTX>+7BY'4,[,:351CAL[6!IMMNMN?554SW?
MG/53_GQTX=%S>JOQ\BL].N;CY>&]K&W,L<YE4:V>EL_2_3]59G6'=>S;.F9=
MN#U%G2#38W)Z?A6BK*9>';:;,GTK:?6QWUMW5[+O9_A?]%9D6?5WKSOJS]9<
M3]GWLR,[+HMQJ++&W6.8'TO=NR?4L]:QC&?I7NL38PA0XB-Q>O\ 6]2B2[G6
M?K1BYO0\K*?7U7IV#5;1]GSL=K:+;Q8\M99B?:'-_5W;6;_5]/?3:Q;^-US&
MR>N9G165V-OP:Z[;+#MV.%HW,V0[?_G,6=]?NGYO4?JX_%P*79%YNH<*V1,-
ML:]_TBWZ+0J657UOI'URS.IXW3+.IXO5,>JJMU+V-V6U>P,O]5S?3K=^=:@!
M&4=-#ZJ%_P!U6K=;]>>FOZ.SJC:,@^OE'!QL4-:;K;]Q8&,BSTFM]KO?9:M'
MI'5K^HNOKR.GY73K<8M#FY+6['[@73C7TOMJOV[?TFSZ"X_!Z)GT_4]F!U;H
M;^I'[?;;?C5VBJVMI+BW+Q';F^J[W;&,;;5ZE;_]&M/ZF=/ZMB]1S;=F9B=#
M?6QN)A]0M%MPM!]]E;=]WV>IK?9L]3](C*$ )5T.FJ@3H]>DDDH5RDDDDE*2
M2224_P#_T?54DDDE.5]9>IV],Z8ZZG2ZUPJK<=0TN#G&S^RQCMO\M<STGI#)
M;F9Y8]SO<VBRRRM\S_.W.958_?\ G[/\]=9U; .<S';M:]M-PN<QSG,!VML:
MW])6U[_YQ['KDOK=];F="+L'']_4]NYQ&5?8RAI$LLR&N%;7V.^E7C?]<M_1
M>GZES!DK'P0'KD29R!J7"Y_,\O++GXYD&$ !CA(2E#B_2G\O V,+'Z;A_7(Y
M& *V95O3LFW*QJGE[9]7'MKR;765U6-MR7_Y^SU?^-W*^K99Q+LB&7-KIKM;
M8QCV-W.^G3M>Y[K'-;[OT;EA?4/ZM9U+<KKG6R]_4.ILV!EQ/JBDP7?:/W+<
MC;7^A_[34TT5_H_YJOIGMOLQ_LS\,&K:&[?5[#CW1O[)DI0,J^:N$$D]M_F9
MY0R "I$>F7RQ/SG;2'RKMZFS?EN<'-HQ:6VDN8]C]?6-GMN#-S=M/L06]3N=
MTWUYJ^TLM91<6396USK*ZRYNQP<_]%:VSZ:)95;:Y[K,,.-FP/\ TO(J<;:A
M$?FO=_;_ ,(DZFUSGO.&)L=6]T6P"ZHAU3]H_=VM_KI@$.W6)^:'Z/S?XWJ0
M3EU]1VF/DR#Y^+@E\OZ'ZM"[JV2S%JR QES'7EAL:'-%E+6/N??16XN?N:VM
MWL]_J^E^B_G:D2GJP=7F9-@:,;' ?0X'5]>W2S=NV?IGL=Z'_!>DI-JM:X.&
M&);8ZYOZ;0/>',L<UO\ +]2SV_OO]3^<3.HL<23A#W.K<0+8$U'=3[1[?8X(
MGV_W1Y\4?WO[W[J![H_2/EP3KY/[G[ZU?4;[L2CTS4<FVTX]CA+ZFO8+'6O:
MUI:]['-I_1,W_P"$KWI9.9GX[*&V>F+;+7,<]E=EH+0RRUCV8]3O6W.V>YN]
M_II68UEF^<.#8]MA<V[:0]H%;+*RW^;?L;L]BC]C=Z3*QB.;Z;W6![<AP?O=
MNWO=:W](_?O_ #DO1V'EZ/SXE$Y:W)- 760;?U>#]/\ O-AF5=]H%#MKHQQ:
M7!KF$N)V_P V]SG,;_(=[T'[7GV58%E;ZF?;0T.#JW.VN-5F2YS2+J_;^CV;
M%&W$LN#-^,_=6TUAXR'->6&-S++&^^S=M_/1B+SZ7ZFT#'.ZH"P -.UU.C6M
M_P!'8]J'I&P%_P"!_P!\NN9T)D!8V&3O&_T?[S&[/O#[JJPS>W(KQZG.!(&]
ME5KGV-!;OV[W^UNQ/D9>7BX;W7FD9)>*J'$EM;B^/3?8UQ<^O;/Z5GJ/_FU&
MW'LM;8U^'_//;8\BZ#O8&-KL8YONK<WTF?035X]E>PC#ES'.L#G7;B7N;Z;K
M'EWTW^G^C]_T*_8Q*H4-!I5BXZZ?O<2"<ERU.MT:R>D2E^YP?HQ2U]0]9^&:
M@#3EUNLD\B QS1H=OY_O4<S,R,?*8V658Q#/TCV/<UQ<[996;JW;,7:W9L?<
MW])ZJ&[$>X- Q',V.>YIKR',(-I]2WW5[?:]_P":D[$?;8UUF,Z(:UX]=VUS
M6GV^LSZ-W]O^<_PB0$+\->L._P#>_=4992"/TK!!K(!\OJ_0_?=-)))0MI__
MTO54DDDE(<V_[-AWY, ^C6^R#H/:TOU^Y<+]0OJ:^WT_K-UX>MF9)^TXU+]0
MUS_TGV[(_-=DV;M^/7_VE9_W8_H_>W4UWTV46C=7:TL>T]VN&UP4@ ! T 3X
MS,8D#3BW/@@BSY+I)))B5))))*4DDDDI22222E))))*4DDDDI22222E))))*
M?__3]527RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22G
MZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI__9 #A"24T$(0      70
M  $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !< 00!D
M &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# $, (  R #  ,0 W
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M!P<&" P*# P+"@L+#0X2$ T.$0X+"Q 6$!$3%!45%0P/%Q@6%!@2%!44_]L
M0P$#! 0%! 4)!04)% T+#104%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04_\  $0@"005: P$B  (1 0,1 ?_$ !\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH 2BJNI7 MK='8X!FB3\6D51_.K5 "T444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 <?\5-8&A^%[.Z8X5M;T>W)]/-U*VB_]GKKZ\+_ &W-;F\-
M?LT^)]7@_P!?I]WI=W'C^]'J5JP_45[;I]]#JEC;7ELXEMKB-9HG'1E8 @_D
M:W<?W,9^;7X+_,B_O-?UU+%%%%8%A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK\8/VZ&=OVKOB!OZ_:+?'/;[+#C],5]#D<4\2WV7ZHX<8_W:]3P>BBBONCR
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MMN']^//1QZC(4\5\WB\MK83WGK'NOU.^E7C4TV9[!12"EKRCI"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ J"^O(=.LY[NYD$5O!&TLDAZ*J@DG\ *GK
M!\>_\B+XC_[!MS_Z*:JBKM(1Y7_PV[\#_P#HH6G_ /?B?_XW2_\ #;OP._Z*
M%I__ 'XG_P#C=?BQ17VO]A4/YG^'^1Y/UR?9'[3']MSX'_\ 10M/_P"_$_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% "5^)7[8'@IO ?[2GC[30FR&;47U"$
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MA8H\_P"T[*N>V<U^&GB[Q9JGCGQ/J?B#6KIKS5=2N'N;B9_XG8YX] .@ X
M KZ#*<"L1-U:B]V/XLXL36=-<L=V9UY>7&H74]U=SR75S.[2RS3.7>1B<EF8
M\DDY.34-%%?='CA]**]$^#/P \;_ !ZUI]/\(Z0UW'"0+F_G/EVMMGH9)#QG
M_9&6.#@&OM?P+_P2CTJ.WCD\9^-[RYG89>VT*!(50^@EE#%OKL7Z5PXC'8?#
M.U26O8VA1G4UBC\Y**_6"/\ X)B_!Y(PIG\2.V/OMJ$>?TBQ^E<[XA_X)5_#
M^\A;^Q?%GB+3)ST-X8+J,?\  0D9_P#'JX5G.$;LVU\C7ZK4/S!HKZT^+/\
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M'N"#7Y[F6#^J5?=^%[?Y'MX>K[2.NZ)J***\@Z@HHHH **** "BBB@ HHHH
M**** "BBB@ K!\>_\B+XB_[!MS_Z*:MZL'Q]_P B+XC_ .P;<_\ HIJN'Q(3
MV/P%HHXHK]7/FPK^@/PG_P BMHW_ %Y0_P#H K^?ROZ _"?_ "*VC?\ 7E#_
M .@"OE,^VI_/]#T<'O(U:***^0/4"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "OGW]OK_ )-)\>_[ME_Z76]?05>#
M_MS:1?Z]^RSXXL-,LKC4;V9;/R[6TB:61\7L!.%4$G !/T!KJPCMB*;?\R_,
MSJ?!+T/Q?^E%==_PI_QY_P!"3XC_ /!3<?\ Q%'_  I_QY_T)/B/_P %,_\
M\17Z9[2'='S_ "OL=#^R_P#\G&_#/_L8;+_T<M?N37XO?LV?"WQGI?[0'PZN
M[SPCKUI:0:]9R2SSZ;,B1J)E)9F*X  [FOV@KX[/)*56%GT/5P=U%W%HHHKY
MH[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFDI:_+Y2<FY2=VSZ%*VB"BBBI&%?-?[7/['.A_M!:%<:MI,$&E>/K:/-M?J
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M/]#TL'O(U:***^0/3"BBLSQ-XBT_PCX>U+7-5N%M-,TZVDN[F9NB1HI9C[\
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M,54#U85^)OQP^-?B'X]>/K[Q/X@G.Z0E+2R5B8K. $[8D'H.Y_B))/6O8R[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ??VVJ6-O>V5Q%=V=Q&LL-Q X>.1&&596'!!!!!%6*^<.\*2EI* /Q!_:O\
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MZ^U^07_!1K_DZG7_ /KRLO\ T0M>UD?^\OT?YHY<7_#^9\R444M?=GC@S%L
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M\C1K'_7[-_Z,-95?K,?A1\T]PK]T/V;/^3>/AC_V+.F_^DT=?A?7[H?LV?\
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M%&H5$10%50,  =A4E%%?/'<%%%% !1110 4444 %%%% !1110 4444 %%%%
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M+#X*\*Z=HMKG"W6JNUU.1_>"J413['?7B>M?MV_'+7)&:3QU<6J$Y$=E9V\
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M +Q4_P 3_,^@I?PX^B"OR"_X*-?\G4Z__P!>5E_Z(6OU]K\@?^"C7_)U.O\
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MA/XGR/JBDI:*^#/8/R;_ ."FGA:;1/VC1JC(1;ZSI-O<))V+1[H67Z@1J?\
M@0KY+K]@?V[_ -G6X^.WPKCN]$M_/\5^'6>[L85'S7,3 >= /]I@JLOJR ?Q
M9K\@)(WMY'CD1HY$)5E88*D=01ZU^A95B(UL-&/6.C_0\3$0<:C?<;79?"WX
MP>+O@OXC_MOP?K,VDWC+LF5</%.F<[)(V!5Q]1QU&#S7&T5ZTHJ:<9*Z9S)M
M.Z/OKP'_ ,%6]4M88X?&7@BUOW'#WFBW30'Z^5('!/\ P,"O<O"?_!2SX-^(
M-BZC<ZSX:<\'^T=/,B@_6 R<>^!7Y)T?6O'J9/A*FRMZ,ZHXJI'K<_=3PG^T
M1\,?'.Q=$\>:#>S/]VW^W1QS'_MFY#_I7H2L)%#*0RD9!'(-?STUT_A/XH>,
M/ ;*WASQ3K&A;3D+I]]+"I^JJP!'L17FU,A7_+NI]Z-XXS^9'[X4M?DK\-/^
M"DGQ7\%S11:]+8^--.7 :/4(EAN H[+-&!S[NKU]W?L__MG_  _^/[1:?9W3
MZ#XF89.BZDP620CKY+CY91UX&&P"2H%>+B,MQ&&7-)77='53Q$*FB>I[Y124
MM>6=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 9/BKPOI/C;P_?Z%KMA#J>DWT1A
MN+2X7*.I_D0<$$<@@$8(K\B?VN_V0=7_ &=?$#:EIPFU3P+?2XL]0(R]LQR1
M!/CHP'1NC =CD#]C*S/$GAO2_&&AWVBZU80:GI5]$8;BTN$W)(I[$?UZ@@$5
MZ6!QT\'.ZUB]T85J*JKS/Y^J/TKZB_; _8KU;X!ZA-XA\/)/JW@&XD^6;!>7
M3F8\1S>JYX63OP#@XW?+O2OT*C6AB(*I3=TSQ)1E!VD%%%'Z5N0%%%% !1FB
MM3P[X<O?%&J1V5C'N=N7=ONQKW9CZ4XQ<G9;F-:M3P].56K*T5JVSV/]DOXZ
M>./@[XX0>&W^W:)<N&U/2;EB+:1.A?\ V) .C#GH"".*]C\>>.M6^(WB:ZUO
M6)O-N9CA47A(4'W8T'91_B3R2:X7PIX5L_".E)9VB[F/S2S,/FD;U/\ 0=JV
MOPKZ/!Y?2PTG6<5[1[O]#^=^)>)*N=5/8TVU0B]%W?=_HNGK</PHI.:,UZQ\
M.+^%36*M)?6Z*,LTB@#U.14 ZUTWPSTHZY\1?#%@%W"XU*W1A_L^8NX_EFLZ
MLU3IRF^B;.C#TW6K0IQWDTOO9^G%+24M?S<?W&%%%% !1110 44E>-?%K]KS
MX6?!KSH=;\307FJQ9!TG2<75SN'\+!3MC/\ UT9:TITYU9<L%=DRDHJ[9[-1
M7B'[,G[5&A?M-6/B&;3-.FT:YTFZ6,V5U,KRR0.N8YCM&!DAU*@G&WKS7MU.
MI3G1FX5%9H(R4E="T445D4%%%% "5\=?ME_L/:/\2]#U+QAX(TZ+3/&MLC7$
MUG:H$BU4 98%!P)NI##[QX;.0R_8U)710Q%3#352F[,B<(U%:1_/2P*L01@C
MMWI*]8_:P\,VOA#]H[X@Z99(L=JNJR3QQKPJ"4"7:!V WXQ[5Y/7Z?3FJD(S
M757/GI+E;05^F_\ P2H\3/??"[QCH#N673=62Z0$_=6>(# ]LP,?Q-?F17Z$
M?\$E9'^T?%%?^6933"?KFZQ_6O*S>/-@YOM;\T=.&?[U'Z'T4M>-_M:_&P_
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M4W_#I_PS_P!#]JW_ ( Q?_%5Y_\ :^#_ )OP9O\ 5:O8_-:BOTI_X=/^&?\
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M6BBBOD#U KC_ (L?%3P_\%_ NH^*_$MU]GTZS7"QI@RW$A^Y%&O\3L>GXDX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[_@GI_R=IX._ZY7W_I'-7[%5^.O_  3T_P"3L_!W_7*^_P#2.:OV*KX;//\
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MUP*VA3I8:+Y4HHERE4>KN<O17L?[5?P:T[X"_$ZW\(:?<27GV;2K66YNI/\
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MX23 [J03V2OU)HKOPN.K81_NWIV>QC4HPJ?$?@%XJ\$>(O ]\;/Q%H6I:%=
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MHHHKC-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@J7,H[NZ2]+NVIY5\#/BKX-^$[/J5]H%]J_B%\JMT&C"6Z=,1@G.2.K=><#
MSGV7_AN3P_\ ]"UJ7_?V/_&H?^&&=&_Z&F^_\!D_QH_X89T;_H:;[_P&3_&O
MB\5BN'\95=:O*3D_\1^H9?@.,\KP\<-A*<(P7_7O[V^K'7/[;7AF\MY8+CPM
M?S02J8Y(I'B974C!!!Z@@]*^$?C9\)?"GBCQ=+JWP^MI_#>G71+S:3?8>*"0
MGGR64DA#_<(^7L<8 ^[/^&&=&_Z&F^_\!D_QI?\ AAG1O^AIOO\ P&3_ !HP
M^)X>PLN:E*2_\".VI#CJHK24?_*9^:'_  HC5?\ H(V?Y/\ X4?\*(U7_H(V
M?Y/_ (5]P_'[]DSQ'\/?!<WB#P/,?%DED#)>:7-#LG,0&2\6TG>1W3&2,XR>
M#\0_\+XU'_H%VO\ WVU>]A\3E>)CS4I77S.&<.-:;M)1_P#*9P_BKPM>>$=4
M-E>;&8H)$DC.5=3D9&?<'\JQZV?%?BJ\\7:I]MO B,J"-(XP=J*,G'YD_G6-
M7'4Y>=\FQ^C8'ZS]6I_7+>TM[UMKGZD_\$L_$C:C\$/$&CR.6;3=;=HQ_=CE
MAC( _P"!+(?QK[.K\_\ _@DQ,S:3\3(BWRK/I[A?0E;@$_\ CH_*OT!K\TS.
M/+C*B7]:(^KP[O2B%%%%>8= 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$SF2:6UBD=S_ !,4!)_.M*O$E'E;B^A]7"2G%374****DL***0YH 6BODO\
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MVGWG8T4E+7SI]L%%%)0 M%?/_P"U9\:+_P"'>G:9HWA^]-GK=ZWVB29 K-#
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M!US_ /'*/[3X?_Z!7]R_^2#^P>,O^@^/_@4O_D#YZ_X;<\=?] KP]_X#3_\
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M^\E]J=]*$CBC!.,G"11KZ#( ']37U7\'_P!D/2='L;?4O&D0U35) '_L[?\
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MS:/S>'!=/"YQ#,L#5]E!:N*5]>J6ND6NFMNG2UBEHHKX\_3 HHHH **** .
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MM-6?YK[U^1^>>'6.E&G7RJMI*F[I>3TDOD_S.BHHHK\_/V4*^./VY"?^$O\
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MCZQ_]-(^RZ***_,#]]$K\K=88R:Q?,>29Y"3_P "-?JG7Y5ZO_R%KS_KL_\
MZ$:_2.#?BK_]N_J?AOB?\&$]9_\ MI^F_@-1'X&\.JHPJZ=;@?\ ?I:W:P_
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M8)D62.1>C*1D$?4&IJ\9_91\;_\ "7?">SM)I-]YH[FPD!//E@ Q'Z;"%_X
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M'$?\^H_B'_$,\%_T$2^Y'YH_\*:\>?\ 0G:[_P""^7_XFC_A3/CS_H3==_\
M!?+_ /$U^EU%'^N&(_Y]1^]A_P 0SP7_ $$2^Y'YH_\ "FO'O_0FZY_X+Y?_
M (FC_A37CS_H3==_\%\O_P 37Z744?ZXXC_GU'\0_P"(9X+_ *")?<C\T?\
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M;\A21U6*",Y^F96'X&OMFOSG,Y<V,J/^MD>[A]*2"O)_VJ/^2#>)_P#MU_\
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MJ/\ A/O"_P#T,>D?^!T7_P 57P#_ ,,^_$7_ *%+4?\ OA?\:/\ AGWXB_\
M0I:A_P!\#_&OG?\ 5S+_ /H,7_DO^9]M_KOG/_0ME]T__D3OOVP]/TBX\::=
MXATC4;*^74+?RKD6DZ2E9(\ ,VTG&4*@?[AKO?V(_&_VK2-:\*3R9DM7%];*
M3SY;860#V#;3]7-?/M]\"_'VFV5Q=W7A;4(K:WC:660H,*J@DGKV -.^!GC?
M_A /BAH>JR2>79M-]FNN<#R9/E8G_=R&_P" BOI*^!IXC*)8.E451P6C5MUJ
MEIY:'P^#S:M@N)(9EB*+HJK+WDTUI+23U2OK[WJ?I"*6DI:_&#^H0K \?_\
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MFD?[L4J E'_FO_ AZ5]O>+/#-GXR\-ZCHFH)OL[Z!H7]5ST8>X."/<"OS/\
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M^PK_ ,@_QC_UUM?Y2U]3U\I_L*7"?9_&4.[]X&M'Q[8F%?5E8\1_\C2M\O\
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M &"9O_1D5?<E>UQ/B:]+,.6G-I66S:/EN L#A,1DRG6I1D^:6KBF^G='!?\
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MQ5_^W?U/P[Q/^#">L_\ VT_3;P+_ ,B3X?\ ^P=;_P#HI:W*Y[X=W"7GP_\
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MG_HYZ_0N#OX];T7YGXMXF_[KAO\ $_R1]^_ ?_DCGA#_ +!\?\J[RN"^ _\
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MEK\@/Z5"BBB@ HHHH ^=OVWO^2:Z+_V%T_\ 1,M?%5?:O[;W_)--%_["Z?\
MHF6OBFOVCA;_ )%L?5G\N>('_(\G_AC^0O/I6OX1\*:CXX\26.B:5!Y]]>2!
M$'91U+,>R@9)/H*QZ]O_ &>_B]X,^$$-]?:IIFJ7^O71\H36T412&$8.U2T@
M.2>2<=@.W/OXZM5H8>4Z$.:?1>?^1\=E.&PV+QD*>+JJG3^TWV[+S>R^\^Q?
MAG\.]-^&'A&ST/3E#",;Y[@C#3RD#<[?7' [  =JZNOG;_AM[P;_ - 77/\
MOU#_ /':/^&WO!O_ $!==_[]0_\ QVOQJID^:UINI4I-MZMZ']/T.)N'L-2C
M1HXB,8Q5DM=$OD?1-%?.Q_;>\&_] 77?^_4/_P =I/\ AM_P;_T!=<_[]P__
M !VLO["S+_GR_P #?_6W(_\ H*C^/^1]%45\[?\ #;W@W_H"Z[_W[A_^.T?\
M-O>#O^@+KO\ W[A_^.T?V%F7_/E_@'^MN1_]!4?Q_P CZ)HKYV_X;>\&_P#0
M&US_ +]0_P#QVC_AM[P;_P! ;7/^_4/_ ,=H_L+,O^?+_ /];<C_ .@J/X_Y
M'T317SM_PV]X-_Z VN?]^X?_ ([1_P -O>#?^@+KG_?J'_X[1_869?\ /E_@
M'^MN1_\ 05'\?\CZ)HKYV_X;>\&_] 77/^_4/_QVD_X;>\&_] ;7?^_4/_QV
MC^PLR_Y\O\ _UMR/_H*C^/\ D?1-?$7[;G[<D7@&&^\ _#^]67Q0P,.HZQ V
M5TX'@QQGO-ZG^#_>^[PW[3G_  4>_MGP_/X9^&<%[I=W<!HKW6[@HLD*="EO
MM9OF/0R9^7^'G##\_P!V:1V=V+.QR68Y))[FO0R_*)1G[3%+;I_F>Q+&PK4U
M*B[I]19)'FD:21F>1B69F.22>I)IM%%?6G %%%=7\*? 5U\4?B1X:\*68;SM
M6OHK8NHR8XRW[Q_HJ!F/LM*4E&+D]D"5W9'Z[?L.^"6\#?LP^"K>6/9<W]NV
MJ2Y&"?/=I$/_ '[:,?A7N]5M-T^WTG3[6QM(EAM+:)888UZ(B@!0/H *LU^5
MUJCJU)5'U=SZ.,>6*B%>3_M4?\D&\3_]NO\ Z50UZQ7D_P"U1_R07Q/_ -NO
M_I5#7=E?^_T/\<?S1XF??\BC%_\ 7N?_ *2SXZ_9]_Y+/X1_Z_5_]!-?H[7Y
MQ?L^_P#):/"/_7ZO_H)K]':^JXP_WNG_ (?U9^>^&G_(NK_X_P#VU!1117P1
M^OA1110 4444 %?GQ^U3_P EZ\3_ /;K_P"DL-?H/7Y\?M4?\EZ\3_\ ;K_Z
M2PU]QPA_O\_\#_\ 2HGY/XE?\BBE_P!?%_Z3,^F?V//^2+VW_7[<?S%>W5XC
M^Q[_ ,D7MO\ K]N/YBO;J^>SC_D85_\ $_S/L^&O^1-A/\$?R"BBBO(/I0K\
MH37ZO5^4!K]+X,_YB/\ MW_VX_"O%#_F#_[B?^V'ZD^$?^14T7_KRA_]%K6M
M63X1_P"14T7_ *\H?_1:UK5^<U?XDO5G[=A_X,/1?D%>;?M#>./^$#^%&LWD
M<GEWMTGV&UYP?,D!&1[JNYO^ UZ0:^-/VUO'']I>+-+\,029ATR'[1<*#_RV
MD'R@^X0 _P#;0U[&28/Z[CZ=-K1:OT7^>WS/F.*\S_LK**U:+M*2Y8^LM/P5
MW\CR;X(^"?\ A8'Q.T+273S+0S">Z&./)C^9P?KC;]6%?I)7RS^Q#X)\FQUS
MQ7/'\TS#3[5B.=JX>0_0G8/^ FOJ:O4XHQGUC'>RB]*:M\WJ_P#+Y'@>'^6_
M4LI^L27O5G?Y+2/ZOYBT445\<?II'-$D\;QR*'C=2K*PR"#U!K\S/B=X/?P#
MX^US0F4B.SN66$MU,1^:,_BA6OTV-?(7[;G@O[+J^B>*H$Q'=1FQN6 XWKEH
MR?<J6'_ !7VO"F+]CC70D])K\5JOPN?E?B'EOUK+(XN*]ZD__)9:/\;,]Y^
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M0A=?]=&_F:_5>ORHU'_D(77_ %T?_P!"-?HG!N]?_MW_ -N/Q7Q/^'!_]O\
M_MA^HWAW_D7],_Z]8O\ T 5HUG>'?^1?TS_KUB_] %:-?G-3XV?ME'^''T05
MYA^T?XX_X07X3ZQ<1R>7>WR_8+;G!WR AB/<(';Z@5Z=7Q?^VGXX_M;QGIWA
MJ"3,&DP^;.H/_+:0 @'Z(%Q_OFO;R/!_7<?3@U[JU?HO\W9'RO%F9_V7E%:K
M%VE)<L?66GX*[^1YA\"/!/\ PGWQ2T+3)(_,LTE^U70(R/*C^8@^S$!?^!5^
MCXKY>_8C\$_9=(UOQ5/'B2Z<6-LQ'/EIAI"/8L5'U0U]0UZ7%&,^L8[V47I3
M5OGN_P#+Y'B< 9;]2RE5Y+WJKYODM(_J_F+1117QY^ED5Q#'=020S(LD4BE'
M1AD,I&"#7YD_$?PC)X#\=:WH,@;%E<LD9;JT9^:-OQ0J?QK].C7Q[^VWX+^Q
MZ]HOBF&/$=[$;.X8#CS$^9"?<J2/^V=?;<)XSV.,=!O2:_%:K\+GY3XB9;]:
MRR.,BO>I/_R66C_&Q] _ 7QO_P )]\+-$U&23S+R*+[)=$G)\V/Y23[L-K?\
M"KT&OCW]B7QM]BU[6?"L\F(KV,7MLI/'F)PX'N4(/_;.OL(5XF=8/ZCCJE-+
M1ZKT?^6WR/J^%LR_M7*:->3O)+EEZQT_'1_,6OFG]MWPG+J'A70O$$*%AIUP
M]O/M'1)0N&/L&0#ZO7TM69XE\.V/BS0;[1]2A\^QO(FAE3H<'N#V(/(/8@5S
M9;C/J.+IXCI%Z^CT?X'?GF6K-\NK8*]G):>JU7XI'P;^S/\ $R#X;?$B)]0E
M$.DZE']CN9&/RQ$D%)#[!A@GL&8U^@:,'4,IRIY!'0U^;OQ<^$6L_"3Q%)97
MT;3Z?(Q-GJ"K^[G3^C#NO;W!!/9_"/\ :GU_X<6<.DZC#_;^B1 +%'))MG@7
MT1\'*C^ZP]@0*_0LZRC^UE''8%J3:V[K_/IK^A^+<+<2?ZN2GE.;Q<(IZ.WP
MOJFNSW35_FGI]XT5X=I/[8GP]U"%6NIM0TM^\=Q:%L?C&6INL_MC?#[3H6:T
MDU'59,<1V]J4Y]S(5Q7P?]CYAS<OL)?=^NQ^O_ZS9+R>T^MPM_B5_NW_  /:
M[^^M],LY[R[F2WM;>-I99I#A44#))/H *_,_XG>+O^$[\?Z[KP#+%>7+/$&'
M(B'RH#[[0M=U\9/VE->^*UNVFPQ#1= W9:SB<L\V#D>8^!D#KM  ]<X!J7]G
M3X&7?Q.\10:GJ-NT?A>RE#SR.,"Y8'/DKZY_B/8>Y%??Y1EZR&A4QN-=I-;=
MEV\VV?CG$F<2XNQ='*\JBY03O>UKO:_E&*OJ^^VQ]<? #P_+X8^#OA:QG4I-
M]E^T.I'*F5VEP?<;\?A7H-(JA5  P!V%+7Y?7K/$59UI;R;?WNY^_8/#QP>&
MIX:&T(J*^2L%?-O[<7_(B>'_ /L)'_T4U?25?-O[<7_(B>'_ /L)'_T4U>QD
M/_(SH^OZ,^9XP_Y$6*]%^:/+?V+?^2O77_8*F_\ 1D5?<=?G-\"?BA:_"/QI
M-K=W8S7\3V;VPBA8*V69#G)_W?UKZ _X;ET/_H6=0_[_ ,=?3\0Y3C<9C?:T
M*?-&R[?YGP/!?$65Y9E2P^+K*,^9NUGL[=D?35%?,O\ PW-H7_0L:A_W_CH_
MX;FT+_H6-0_[_P =?-?ZOYG_ ,^7]Z_S/O/]<LA_Z"5]TO\ (^FJ*^9?^&YM
M"_Z%C4/^_P#'7?\ P=_:&T[XQ:U?:=9Z3=:<]K;_ &AGGD5@PW!<#'UK"ODV
M/P]-U:M)J*W=U_F=6%XHR?'5HX?#XA2G+96EK]Z/6Z*2EKQ3ZDX#X\>%9/&7
MPE\2:9 ADN3;_:(57JSQ,) H]SMQ^-?GIX5\07'A/Q-I>M6HS<6%S'<HI. V
MU@=I]CC'XU^I)KX9_:8^ UUX%UVY\1:-:M+X:O9#(XB&?L4C'E6'9"?NGH,[
M?3/Z%PKCJ4>? 5GI/5>?1KY]#\7\0<HKS=+-\*KNGI*VZ2=U+Y.]_ET/M'PK
MXFL/&7AZPUK2YA/8WD0EC8=1ZJ?1@<@CL0:UJ_.;X2?'3Q%\(;IUT]TO=)F;
M=/IMP3Y;'^\I'*-CN.O&0<"OI?0?VT_!FH6Z_P!IV.IZ5<8^9?+6:/\ !E.3
M^*BO+S#AO&86H_81YX=+;_-'T&3<<Y9CZ$5BZBI55NGLWW3VMY/7\SZ"I#7A
MFH_MD?#ZSA+0-JE\_9(;3:?S=EKPWXL_M9:[X\L9])T6V_X1_29@4E99-]Q,
MIZJ6& H/<#GMG&17-A>'LPQ,U&5-P75O3\-V=V8<:9-@:3G&LJDND8ZW^>R^
M;^\P_P!I[XBV_P 0OB=.;"43:9ID8LH)%.5D()+N/8L2 >X4&O>OV*_",FC_
M  _U+6YDV/J]T!%D?>BB!4'_ +[:0?A7S3\&_@[JWQ<\11VUNDEOI$+@WVH;
M?EB7NH/=R.@_$\<U^B.BZ/9^'](L],L(5M[*TB6&&)>BJHP!_P#7KZ3B'$T<
M%@X950=VK7]%KKYMZGPO!>!Q6:9G5X@Q:LG?E\V]-/**T_X9EP4M%%?FQ^Z!
M1110 5\C_MU?\A'P=_URNOYQ5]<5\C_MU_\ (0\'?]<KK_T**OI^&O\ D:4O
M^WO_ $EGP7'7_)/XC_MS_P!+B'["G_(0\8_]<K7_ -"EKZXKY'_85_Y"'C'_
M *Y6O\Y:^N*.)?\ D:5?^W?_ $E!P+_R3^'_ .W_ /TN04445\P?>A1110!\
MJ_MV?\>?@S_?O/Y0USW[#G_([>(O^P<O_HQ:Z']NS_CU\&?[]Y_*&N>_8;_Y
M';Q%_P!@Y?\ T8M?I]'_ ))A^C_]+/P+$_\ )>Q]8_\ II'V71117Y@?OHAK
M\W_CQX3E\&_%CQ'8LA6&6Z:[@/8QRG>N/IN*_537Z0UXK^TK\#V^*FAQ:CI*
MJ/$>G(1"K$ 7,74Q$]CGE2>,DCOD?5<.YC# 8NU5VA-6;[=G_7<_/>-LEJYQ
MEU\.KU*;YDNZZI>?7Y6,W]D7XG6_BCP)'X:N)E&KZ*I18V/,MN3\C#_=SL/I
MA?6O>Z_+G3=2UKP'XC2ZM);G1]9L92,X*21L."K _B"",'H:^G? O[;=O]FC
MM_%VC3+.HP;W2\,K^YC8C'X,?H*]C.N':\JTL3@US1EJUU3?;NCYGA;C7"0P
ML,#F<N2<%RJ3V:6U^S6SOIYW/JJD->-Q_M;_  U>+>=7N8V_YYM8R[OT7'ZU
MQ_C']MG0;&VDC\-Z3=ZG=XPLUZ!#"#V. 2S?3"_6OEZ>2YC5ERJC)>JLOO9]
M_7XIR7#P]I+%0:\GS/[E=G5?M9>/+;PK\+;O2Q*O]I:T1:PQ9^;RP097QZ;?
ME^KBOE7]G/P_+XB^,WAF*-"4M;C[;(W95B!<$_\  @H^I%<OXP\9:[\3/$SZ
MEJUQ)J&H7#".*.->%&?ECC0=!D\ =2<\DYK[)_9?^",WPST.?6-9B\OQ#J2!
M3">MK#U$9_VB<%OHH[&OO:D*?#N4RI3E>I._WM6T\DOZU/R"C5K<:<1T\33@
MU0I6WZ13OKYR?3MZ7/<Z6D%+7Y0?T09GB;7K;POX?U+6+P[;6QMWN).>2%4G
M ]SC ]S7YF7,VH^/O&$DA'VC5=8O<A1_%+*_ 'XL!7V!^V?XX_L/P%9^'H)-
MMSK,^90#SY$9#'\W*?4 UXS^R#X)_P"$F^* U6:/?::)";@Y&1YS96,?7[S#
M_<K],X?A'+LMK9C46KV]%HOOEH?A'&526=9YALDI/2-K^LM7]T5?YL^U?"/A
MVW\(^%]*T6U_U%A;1VZG&-VU0"Q]R<D_6M>D%+7YK*4IR<I;L_<Z=.-*"IP5
MDE9>B"DI:*DT/@O]K;P7_P (M\5[B_ACVV>LQ"\4@<"3[L@^NX;O^!U[5^Q?
MXW_MGP+?>'9I,W&CS[X@?^>,I+ #Z.'_ .^A6C^V)X+_ .$B^&2:Q#'NNM%G
M$Q(&3Y+X20?GL;Z*:^;OV9O&W_"$_%O2FED\NRU(_P!G7&3@8D(V'\'"<^F:
M_4H?\+&0<N\Z?YQ_SB?S_5_XQKC%3VIUG^$]_NGKZ(_0FEI*6ORT_H *_,?X
MH?\ )3/%O_87O/\ T<]?IQ7YC_%#_DI?BW_L+W?_ *.>OT+@[^/6]%^9^+>)
MO^ZX;_$_R1]^? ?_ )(YX0_[!\?\J[ROD/X=_M?:/X+\#Z+H4_A^^N9;"V6!
MIHYD"N1W -=%_P -S:%_T+&H?]_XZ\C%9%F53$5)QHNS;>Z[^I]-E_%V1T<'
M1I5,2E*,8IZ2W27D?35%?,O_  W-H7_0L:A_W_CH_P"&YM"_Z%C4/^_\=<O^
MK^9_\^7]Z_S/0_URR'_H)7W2_P CZ:HKYKL_VW-$O+N"W7PUJ"M+(L88SQX&
M2!FOI.O.Q> Q.!<5B8<M]MNGH>UEV<8'-E)X&JI\MKZ/2^VZ78#7RI^U%\9_
M'G@;Q<="TRZBTG2;BW2>WNK>+,TJD8<%VS@A@?N@'&/6OJRO,_CS\'X/B]X2
M^RQLD&M69:6PN'Z!B/FC;_9; ^A /;!ZLGKX?#XR,L5%2@]-5>WG\CS^)L)C
M<9EE2GE]1QJ+56=F[;QOYK\;'GW[)?QH;Q5I,WA;7+^2XURV=YK::ZD+R743
M$LPW$Y9E)/\ P$C^Z:^C*_+K4-/UOP#XD:WN8[G1M:L)0>I22-@<AE(_,$<$
M<BOHGX>_MK75A:Q6GC#2WU'8 /[0T_:LK>[1G"D^X*_2OK,YX=J5:CQ> 2E&
M6K2_-=&G_P ,?G7"_&M'#T%E^;MPG#12:>RZ2ZIK:_WV>_U[17C%I^UU\-KB
M$/)J=W:M_P \Y;*0D?\ ?((_6L7Q)^VEX,TR!AI-GJ.LW'\(\L01'ZLQR/P4
MU\E')LQG+E5"7W6_%Z'Z/4XGR6G#VDL7"WDTW]RN_P #U/XL>+K7P/\ #S7-
M7NI%3R[9TA4GF25@5C4?5B/PR>U?G-X/T"7Q5XKT?1X5W27UW';\#H&8 D^P
M&3^%=/\ %CXT^(?B[J$<FJ2+;V$#$V^GV^1%'VW'/+-C^(^^,9Q7OO[)WP)N
M]#F7QKK]LUO=-&5TVUE&'16&&F8=B02%'H2>XK[["T5PWEU2K7DO:3V7GT7R
MW;/QW,,3+CG.J-#"0?L:>[?:_O-]KVM%?TOJ*EI*6OR@_HD**** "BBB@#YU
M_;>_Y)KHO_873_T3+7Q5S7VM^V]_R371?^PNG_HF6OBI5+, H))X  ZU^T<+
M?\BV/JS^7/$#_D>S_P ,?R/2?@;\%KOXS:[>6HNFTW3K.+S)[P1>9ACPB 9&
M2<$]>BFO;?\ AA6T_P"AQF_\%X_^.5['\!/ALOPQ^'-AITL874[@?:KYN_FL
M!\O_  $87\">]>BU\=F7$F,EBIK"5+06BT3O;KJNI^FY'P-EL<!3>8T>:K)7
M>LE:_2R:VZ^=SY8_X85M?^ARF_\ !</_ (Y2?\,*6O\ T.,W_@N'_P <KZHH
MKS/]8LT_Y_?A'_(][_4GA_\ Z!O_ ":?_P D?*__  PI:_\ 0Y3?^"X?_'*7
M_AA6T_Z'&;_P7#_XY7U/11_K%FG_ #^_"/\ D'^I/#__ $#?^33_ /DCY7_X
M84M/^AQF_P#!</\ XY1_PPI:?]#C-_X+E_\ CE?5%%'^L6:?\_OPC_D'^I/#
M_P#T#?\ DT__ )(^6/\ AA2U_P"ARF_\%P_^.4?\,*VO_0XS?^"X?_'*^IZ*
M/]8LT_Y_?A'_ "#_ %)X?_Z!O_)I_P#R1\L?\,*VG_0XS?\ @N'_ ,<H_P"&
M%;3_ *'&;_P7#_XY7U/6+XR\9Z)\/_#=[K_B+4H-)TBR3S)[JX;"J.P ZLQ/
M 49))  )IKB+-9.RJ_A'_(/]2>'_ /H&_P#)I_\ R1\V7G[$.FZ?:S75UXX:
MVMH4:26::Q54C4#)9B9<   DD^E? /Q]^(6BP:]>>'O ^M3ZSHT.8YM8: 0?
M:6Z$1#<3Y?\ M'!;TQR>U_:V_;;UOX^74_A_P^9]#\!QOQ;YVSZ@0>'G(/"]
MQ&.!P3DXQ\N^]?6X/$9C*%\75O?I9+\D<2X9R/#U8U,/ATG'JW)_@VU^ 444
M5T'T 4444P"OO3_@EQ\&6U+Q%KGQ+OX/]&T]#IFF,PZSNH,SC_=C*K[^:WI7
MQ+X+\(ZGX_\ %FD^'-%MS=:KJ=REK;Q#H68XR3V4=2>P!-?N7\'?ACIOP;^&
MN@^$-+ :WTRW$;S;<&>4_-)*?=G+-[9QVKY[.,5[&C[*.\OR.W"T^:?,]D=G
M1117PI[ 5R/Q6\"'XF> M4\-B^_LXWOE?Z28O-V;)4D^[N&<[,=>]==16M*I
M.C4C5INTHM->J,,10IXJC.A65XS337=-6>WD?-WP]_8_?P+XTTC7SXL6]&GS
MB;[/_9WE[\ C&[S3CKZ&OI"BEKJQF/Q&8353$RYFE;9+\DCSLLRC!9/3E1P,
M.6+=WJWKMU;"BBBN ]@**** "BBB@!#7SU\5OV3G^)GC[5/$@\4+IPO?*_T8
MV'F[-D21_>\P9SLST[U]#45W8/'8C 5'5PTN5M6V3T^=^QY.995@\XHJAC8<
MT4[VNUK9KHT]FSA_@Y\-3\)_!<>@'4?[4*3R3?:/)\K.XYQMW-T^M=Q117/6
MK3Q%256H[REJSMPN&I8.C##T%:$59+?1>NH4445B=(AKY-_X83?_ *'9?_!7
M_P#;J^LZ*]/!9EBLOYOJT^7FM?1/;;=/N>#FF1Y?G7)]?I\_)>VLE:]K[-=D
M4]'L?[+TFRLM_F_9H$AWXQNVJ!G';I5RBBO-;<G=GN1BHI16R$-?,WC+]CF\
M\:>*M5UR[\:JL]_</.4_LPD("?E0'SNBC 'L*^FJ*[\'F&)R^3GAI<K?DG^:
M9X^:9/@LYA&GCH<T8NZ5Y+7Y-'-?#GP3;?#OP5I7AZVD\]+*+:TVS;YKDEG?
M&3C+$G&3CIFNEHHKCJ5)59NI-W;=WZL]2C1IX>E&C25HQ2279+1!11169L%<
M;\6OAQ;_ !4\$WGA^>X^Q/*Z2PW7E^8875LAMN1G(W+UZ,:[*BM:56="I&K3
M=I1=T<^(P]+%T9X>M&\))IKNF?-/@;]C^\\"^+M)U^T\:+)-87"S>7_9I7S%
MZ,A/G<!E)7\:^E:6BNO&8_$9A)3Q,N9K39+\DCSLLR?!9/3E2P,.6,G=J[>O
MS;"L_P 0:7_;F@ZEIHE\G[9;26_F;=VS>I7.,C.,UH45PQDXM26Z/6G%5(N$
MMF?*-O\ L,O;W$4O_":*VQ@VW^R^N#_UVKZMI:*]#&YEBLPY?K,^;EO;1+?T
M2['BY7D>7Y*IK 4^3GM?63O:]MV^["BBBO-/=$KP;XO_ +*=A\3/%3:[8ZP-
M!N)T NHQ:><LSC@2??7!QP>N< ]<Y]ZHKMPF,KX&I[7#RY9;?U<\O,<KP>;4
M?J^-I\\;WZK7U5F>2? [X*:G\&OM]L?% UC2;OY_L9LC%Y<HP-ZMYC=1P1CG
M"^E>M"EHK/$XFKBZKK5G>3WT2_*QK@<#0RVA'#896A'97;M\VVPKA/C-\,3\
M6O!IT$:D-+/VB.?[08/.^[GC;N7KGUKNZ*BC6GAZD:M)VE'5&N*PU+&4)X>N
MKPDK-:K3Y:G@7P?_ &6V^%/C:'Q ?$HU/RX9(OLXL?)SN&,[O,;I]*]\I:*W
MQ>,KXZI[7$2O*UMDOR.3+<KPF4T?J^"ARPO>UV]7ZMOH%%%%<1ZH4444 (<U
M\I7'[#$EQ<2R_P#":*-[%L?V7TR<_P#/:OJZDKTL%F6*R_F^K3Y>;?1/;U3[
MGA9ID>7YTH+'T^?DO;62M>U]FNR*^FVG]GZ?:VN_S/)B6/=C&=H SC\*LT45
MYS=W=GN12BDD(:^8_%G[&UYXN\3:IK=YXV7[1?W#W#+_ &83MW'(4?ON@& /
M85].T5WX/,,3E\G+#2Y6]]$_S3/&S3)L#G,(T\=#F47=:R6OR:.=^'W@VW^'
M_@O2?#]J_G1V,(C,VW;YCDDN^,G&YBQQDXS71445QU*DJLW4F[MZL]6C2AAZ
M<:-)6C%))=DM$%%%%9FH5Q?Q<^&MO\5_!-SH$]S]BD>1)H;KRO,\EU/7;D9R
MI9>H^]7:45K1JSH5(U:;M*+NCFQ.'I8NC/#UXWA)-->3/FKP)^R!>> _&&DZ
M_:>,UDFL)UE\O^S"OF+T=,^=QN4E?QKZ4I:*Z\9C\1F$U/$RYFM-DOR2//RS
M)\%D].5+ PY8R=VKMZ[=6PHHHKSSV3.U[P_IGBC2YM.U:Q@U"QF&'@N$#*?0
M^Q'8CD5\\>-/V)=&U"62?PUK,^D%N1:7:>?$/96R& ^NXU],45Z6#S'%X!WP
M]1KRZ?<]#P\RR3+\W26-HJ36SV:^:L_EL?#M]^Q;X[MY"(+O1[M.S)<NI_$,
M@IVG_L5^.;J0"ZO='LH^[-<2.WX )S^8K[@HKWO]:LQM:\?N/D/^(>Y)S<UI
M6[<W_ O^)\Z>!?V+_#FASQW7B+4)O$$RG=]F1?(M_P 0"6;\P/45]!V%A;:7
M9PVEG;Q6MK"H2.&% B(HZ  < 58HKY[%X_$XZ7-B)N7Y?=L?9Y;D^ RF#A@J
M2A?=[M^K=V_O"BBBN ]@*\U^.?P=/QFT'3]-&K#2#:7/VCS#;^=N^0KC&]<=
M>M>E45T8?$5,+5C6HNTEM_3./&8.ACZ$L-B8\T);J[7XJS/DS_AA)_\ H=E_
M\%9_^/4O_#"4G_0[+_X*S_\ 'J^LJ*][_63-/^?O_DL?\CX__4;A_P#Z!_\
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MA?\ 0:T__P "H_\ &C_A+M"_Z#6G_P#@5'_C1[*I_*_N#ZQ1_G7WHUJ*R?\
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M (T>RJ?RO[@^L4?YU]Z-:BLG_A+M"_Z#6G_^!4?^-'_"7:%_T&M/_P# J/\
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M_P :/^$NT+_H-:?_ .!4?^-'LJG\K^X/K%'^=?>C6HK)_P"$NT+_ *#6G_\
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M6G_^!4?^-'_"7:%_T&M/_P# J/\ QH]E4_E?W!]8H_SK[T:U%9/_  EVA?\
M0:T__P "H_\ &C_A+M"_Z#6G_P#@5'_C1[*I_*_N#ZQ1_G7WHUJ*R?\ A+M"
M_P"@UI__ (%1_P"-'_"7:%_T&M/_ / J/_&CV53^5_<'UBC_ #K[T:U%9/\
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M\,F_$S_H!P_^!\'_ ,72_P##)OQ,_P"@'#_X'0?_ !=??U%'^MV/_EA]S_\
MD@_XAOD__/RI_P"!1_\ D3X _P"&3?B9_P! .'_P.@_^+I?^&3?B9_T X?\
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M .2#_B&^3_\ /RI_X%'_ .1/@#_ADWXF?] .'_P.@_\ BZ/^&3?B9_T X?\
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M_P#Y(/\ B&^3_P#/RI_X%'_Y$^ /^&3?B;_T X?_  /@_P#BZ/\ ADWXF?\
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M /D@_P"(;Y/_ ,_*G_@4?_D3X _X9-^)O_0#A_\  Z#_ .+H_P"&3?B9_P!
M.'_P.@_^+K[_ **/];L?_+#[G_\ )!_Q#?)_^?E3_P "C_\ (GP!_P ,F_$S
M_H!PC_M^@_\ BZ/^&3?B;_T X?\ P.@_^+K[_HH_UNQ_\L/N?_R0?\0WR?\
MY^5/_ H__(GP!_PR;\3/^@'#_P"!T'_Q='_#)OQ-_P"@'#_X'0?_ !=??]%'
M^MV/_EA]S_\ D@_XAOD__/RI_P"!1_\ D3X _P"&3?B;_P! .'_P/@_^+H_X
M9-^)G_0#A_\  ^#_ .+K[_HH_P!;L?\ RP^Y_P#R0?\ $-\G_P"?E3_P*/\
M\B? '_#)OQ,_Z </_@=!_P#%T?\ #)OQ-[:'#_X'P?\ Q=??]%'^MV/_ )8?
M<_\ Y(/^(;Y/_P _*G_@4?\ Y$^ /^&3?B9WT.'_ ,#H/_BZ/^&3?B9_T H?
M_ Z#_P"+K[_HH_UNQ_\ +#[G_P#)!_Q#?)_^?E3_ ,"C_P#(GP!_PR;\3/\
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M^3_\_*G_ (%'_P"1/@#_ (9-^)G_ $ X?_ Z#_XNC_ADWXF?] .'_P #X/\
MXNOO^BC_ %NQ_P#+#[G_ /)!_P 0WR?_ )^5/_ H_P#R)\ ?\,F_$S_H!P_^
M!\'_ ,71_P ,F_$S_H!P_P#@=!_\77W_ $4?ZW8_^6'W/_Y(/^(;Y/\ \_*G
M_@4?_D3X _X9-^)G_0#A_P# ^#_XNC_ADWXF_P#0#A_\#X/_ (NOO^BC_6['
M_P L/N?_ ,D'_$-\G_Y^5/\ P*/_ ,B? '_#)OQ-_P"@'#_X'P?_ !='_#)O
MQ-_Z </_ ('0?_%U]_T4_P#6['_RP^Y__)!_Q#?)_P#GY4_\"C_\B? '_#)O
MQ,_Z </_ ('0?_%UVGP;_9Q\>^$/B=X?UC5-(B@T^TG+S2+>0N5&QAT#$GDC
MI7V716-;BG'5J<J4HQM)-;/K\SHPWA]E6%KPQ$)U+P::NXVNG?\ E$%+117Q
MQ^FA1110 4444 ,:)7D1RH++G:3VS3J6B@ HHHH **** "DHKX8_;R_;1;P5
M%>?#CP)?8\02*8]7U:W?FQ0CF"-ATE(^\P^X#@?,?EZL/AYXJHJ=,SJ5%3CS
M,SOVX/VYCH+7_P ._AS?_P#$R^:#5M>MG_X]NS00,/\ EIV9Q]WH/FR5_.'<
M6))Y).232$D\YS17Z)A<+3PE/DA\WW/#J5)5'=A11^%%=ID%%%% !S2TE==\
M+/A7XD^,GC*S\,>%[!K[4;DY9CD101@C=+(V/E1<\GZ  D@&)24$Y2=D"3;L
MB#X;_#?Q#\6O&%AX9\,Z>^HZI>-A57A(T'WI)&_A1>I8_P R!7[%_LQ_LS:!
M^S;X+6PLME_X@O%5]4U@IAYW'1%[K&N3A?Q/)IW[-'[,OAS]F_PC]ATX+J&O
M7:JVIZQ(F)+AQ_"H_AC!Z+^)R>:]CKX3,LR>*?LZ>D/S/9H4/9^]+<*6BBO"
M.P**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2
MEK@/CI\8M(^!/PUU7Q=K!#K;+Y=K:AL-=7#9\N)?J1DGLH8]JN,95)*,5=L3
M:BKL\:_;B_:PC^ OA,>'_#]PC^.M8B/D$8/V" Y!N&']XD$(#W!/1<'\C[FY
MFO+B6XN)7GGE8R22RL6=V)R6)/4D\YK>^(7C[6OBAXTU7Q1X@NC=ZMJ4QFE?
MHJ]E11V50 H'8 5SM?HV!P<<'2Y?M/=GA5JKJROT"BBBO2, HHHH ***]:_9
MU_9L\4?M'>+1INC1_8](MF4ZCK,R$PVB'M_MR$9VH.3WP 2,ZE2-*+G-V2'&
M+D[(Q/@I\$?%'QZ\:0>'?#%GYLG#W5[*"(+.+.#)(V.!Z#J3P :_87]GO]G7
MPO\ LZ^#ET?0HOM%_.%;4-7F0">\D'<_W4&3M0< 'N22=CX,_!7PO\"?!EOX
M<\+V7D0+A[BZDP9[N7&#)*V.2?3H!P !7>5\%F&8RQ;Y(:0_/U/9HT%35WN)
M2T45XIUA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 E?D7^W]^T(WQB^+$N@Z7<^9X5\,.]K;^6WR7-SG$TWN,C8I]%R/
MO&OO_P#;1^-3?!'X$ZQJ-E/Y.O:G_P 2O3&4X999 =T@]-B!V!_O!1WK\7>^
M>M?5Y)A;MXB731?JSS<74^P@HHHK[ \P**** #%':BOI_P#9!_8MU7]H#48O
M$&OK/I'@&WDP]P!MEU!E/,4.?X<C#2=!R!DYV\]:M##P=2H[)%P@YOEB<Y^R
MO^R3XA_:0U_SCYND>#K.3;?ZPR?>/4PP@\-(1^"@Y/8-^NWPZ^'/A[X4^$K+
MPWX8TZ/3-*M%PL:<L['[SNW5G/=CR:T?"_A?2?!?A^QT30]/@TO2;&,0V]I;
MKM2-1_,YY)/))).2:U:^ QV/J8R7:*V1[5&BJ2\PHHHKRSH"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6D/OP* /R
MR_X*>_$]O$_QETWP?!+FR\-60,J \?:IP)&/X1B'Z9;UKXUKL?C)XT?XB?%?
MQ?XE9_,34]4N+B+G.(C(?+7Z!-H_"N.K]0PM'V%"%/LO^'/GJDN>;D%%%!KK
M,P_&BBOLK]B7]B.7XKW%KXW\<VDD'@R)M]G8295]48'J>XA!ZG^+H.,FN;$8
MBGAJ;J5'H7"$JCY8E/\ 8P_8AN_C-<6OC#QG!-8^!HGW06W*2ZJP/13U6+/5
MQR>0O=A^J&EZ79Z+IMKI^GVL-E8VL:PP6UN@2.)%&%55'  '85):6L%C:PVU
MM#';VT*+'%#$H5$4# 50.  ,# J:OSS&8RIC)\TMNB['N4J4:2L@HHHK@-@H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*^*O 7@O4?B-XTT3PSI,?F:CJUW':0Y'"EF W'_949)/8 U^Z_PY\":9\,?
MNA^%='C\O3M)M4MHN "^!\SM_M,V6/NQK[/.,4Z-+V47K+\O^">3A:?-+F>R
M.BI:**^&/8"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/_?E8ORKZ&KLS&M[?$S?1:+Y&-"/)32"BBBO-.@**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KSS]HBUEOO@'\1[>%=\TWAS4(T4=V-NX _,UZ'63XKT]=6\-ZG9.,K<V[P
MD>H88_K6E.7+-2[,4E=-#O"^@P>%_#.D:+;<6VG6D-G%@8^6- @_05J445#=
MW=C"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !2>M%% "T444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139905296971560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>May 12, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 12,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SALARIUS PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-5087339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite X<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2450 Holcombe Blvd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">834-6992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SLRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001615219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>flks-20220512_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="flks-20220512.xsd" xlink:type="simple"/>
    <context id="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001615219</identifier>
        </entity>
        <period>
            <startDate>2022-05-12</startDate>
            <endDate>2022-05-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF80L2ZyYWc6MjMwNjkyMjExODRhNGEwZThiMDhkZDczYWU1ZWFkMTIvdGFibGU6OGE1NWJiYTM1MmQ3NDUxOWJiZGUzYjAwZjcyYjNiZGEvdGFibGVyYW5nZTo4YTU1YmJhMzUyZDc0NTE5YmJkZTNiMDBmNzJiM2JkYV8xLTEtMS0xLTIxOTQ2_37c2a4f8-c830-487d-9f3f-de15bad61aab">0001615219</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF80L2ZyYWc6MjMwNjkyMjExODRhNGEwZThiMDhkZDczYWU1ZWFkMTIvdGFibGU6OGE1NWJiYTM1MmQ3NDUxOWJiZGUzYjAwZjcyYjNiZGEvdGFibGVyYW5nZTo4YTU1YmJhMzUyZDc0NTE5YmJkZTNiMDBmNzJiM2JkYV8yLTEtMS0xLTIxOTQ2_3c8ed883-21ff-4a64-a454-ea84728db03d">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGV4dHJlZ2lvbjpkNGExNTZkYzRmMzM0ZjViOWEzZThiMjczY2QzYmViZl8yMjMz_045bd17d-a73f-45ae-9a72-1f501cc96906">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGV4dHJlZ2lvbjpkNGExNTZkYzRmMzM0ZjViOWEzZThiMjczY2QzYmViZl8yMDk_19b4318c-ac6f-4344-afad-ec77f805e632">2022-05-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGV4dHJlZ2lvbjpkNGExNTZkYzRmMzM0ZjViOWEzZThiMjczY2QzYmViZl8yMjM0_4e0ee0dd-e27d-4c65-a86c-72d7d077361e">SALARIUS PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8wLTAtMS0xLTIxOTQ2_dc6988a4-21dc-48f3-8489-53b72c667b9d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8wLTItMS0xLTIxOTQ2_4b1231fd-717c-4d3b-88df-08ab7a0233a0">001-36812</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8wLTYtMS0xLTIxOTQ2_2b058e50-e146-4441-b053-4f0a32a20014">46-5087339</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8zLTAtMS0xLTIxOTQ2L3RleHRyZWdpb246OGYzMTc1YTVjMWE5NDI4MTlmNmU3NDY4YjA1OWFjNWRfNQ_16f36e97-56e1-43c0-8d7c-3c61149161d7">2450 Holcombe Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8zLTAtMS0xLTIxOTQ2L3RleHRyZWdpb246OGYzMTc1YTVjMWE5NDI4MTlmNmU3NDY4YjA1OWFjNWRfOA_2b1c85fe-ff75-41e9-8315-b72dfade506c">Suite X</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8zLTAtMS0xLTIxOTQ2L3RleHRyZWdpb246OGYzMTc1YTVjMWE5NDI4MTlmNmU3NDY4YjA1OWFjNWRfMTE_a7637e8d-bb55-4b76-8e27-4cb1dc9134c8">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8zLTAtMS0xLTIxOTQ2L3RleHRyZWdpb246OGYzMTc1YTVjMWE5NDI4MTlmNmU3NDY4YjA1OWFjNWRfMTU_59f14441-dc45-4059-a4c6-11cea178942d">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NmRlOGEzYzAzMmEwNDA2Yjg4MmQ5ZDM2MDU0Mzk3ZWIvdGFibGVyYW5nZTo2ZGU4YTNjMDMyYTA0MDZiODgyZDlkMzYwNTQzOTdlYl8zLTQtMS0xLTIxOTQ2_c516a4b0-9704-4e12-8e1d-6969ecfe47ed">77021</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGV4dHJlZ2lvbjpkNGExNTZkYzRmMzM0ZjViOWEzZThiMjczY2QzYmViZl8yMjM1_5945eb69-a2d2-45ca-8731-63d361a91dbb">832</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGV4dHJlZ2lvbjpkNGExNTZkYzRmMzM0ZjViOWEzZThiMjczY2QzYmViZl8yMjM2_dc1429e6-b98e-4967-8996-224041e1a7d7">834-6992</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6MmMxMmMzOTEwM2I2NDJjN2EzNDlkNzMwYmQ0NmRhNjMvdGFibGVyYW5nZToyYzEyYzM5MTAzYjY0MmM3YTM0OWQ3MzBiZDQ2ZGE2M18wLTAtMS0xLTIxOTQ2_825e9974-0a4f-45c9-8adc-61babd1cc37b">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6MmMxMmMzOTEwM2I2NDJjN2EzNDlkNzMwYmQ0NmRhNjMvdGFibGVyYW5nZToyYzEyYzM5MTAzYjY0MmM3YTM0OWQ3MzBiZDQ2ZGE2M18xLTAtMS0xLTIxOTQ2_0f34fe3f-f762-4530-b77d-9945c6195ba0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6MmMxMmMzOTEwM2I2NDJjN2EzNDlkNzMwYmQ0NmRhNjMvdGFibGVyYW5nZToyYzEyYzM5MTAzYjY0MmM3YTM0OWQ3MzBiZDQ2ZGE2M18yLTAtMS0xLTIxOTQ2_5059f7b3-5644-46c6-8177-2dd57cb0b635">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6MmMxMmMzOTEwM2I2NDJjN2EzNDlkNzMwYmQ0NmRhNjMvdGFibGVyYW5nZToyYzEyYzM5MTAzYjY0MmM3YTM0OWQ3MzBiZDQ2ZGE2M18zLTAtMS0xLTIxOTQ2_6fee2973-4d09-4f2c-99f4-70f4f9e547b5">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NWM1ODhjNmJjZWMzNGExOTlmMDRkMWRmNWFhYjE0Y2QvdGFibGVyYW5nZTo1YzU4OGM2YmNlYzM0YTE5OWYwNGQxZGY1YWFiMTRjZF8xLTAtMS0xLTIxOTQ2_976b7b58-c252-4d10-8c1d-3a416dcf510d">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGFibGU6NWM1ODhjNmJjZWMzNGExOTlmMDRkMWRmNWFhYjE0Y2QvdGFibGVyYW5nZTo1YzU4OGM2YmNlYzM0YTE5OWYwNGQxZGY1YWFiMTRjZF8xLTItMS0xLTIxOTQ2_0442f2cd-6aa2-4cd2-8da5-ab3afca90af2">SLRX</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="i7c4c92f244d84648ad94262aa286148b_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjViNzY5MzQ0ODliODRjZTVhYTgyYTZjYzUyMjgxOTY4L3NlYzo1Yjc2OTM0NDg5Yjg0Y2U1YWE4MmE2Y2M1MjI4MTk2OF8xL2ZyYWc6ZDRhMTU2ZGM0ZjMzNGY1YjlhM2U4YjI3M2NkM2JlYmYvdGV4dHJlZ2lvbjpkNGExNTZkYzRmMzM0ZjViOWEzZThiMjczY2QzYmViZl8yMjM3_59b28f62-4eba-43ac-ab19-11020c744a44">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M6-TWC$J+ ^)2&3AN%K<;..!S;3^ ]RNES$?#GCG+?QF,_@902P,$%     @
MPH&L5)^@&_"Q @  X@P   T   !X;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@
M;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W
M)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP
M4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB62;&W
M8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM
M5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLY
MS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5<D
M].)3"6T@L-5)](1&,80)"L2_C!9B7X2]_:VPI!&/QGWL_&[TH'_OC./WEE>B
M'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0<O(%;2AZY=>)P
M:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%P<T:L#.EL)
M7(0;^A7N5WGF0/:=D$[H43N*LN3ZQ3GUX1W;^PO\*KY?7_**==+M9G!#S_(7
M7HI.Y?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-'
M,)^ Q1' L#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X
M3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3
MB.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,
M9AE2G0P^\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3
M_ 102P,$%     @ PH&L5)>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2
MN6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9>3T\$MP>
M:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y +AEF
MM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;
M&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ
M8K3^-8+)#^Q^ %!+ P04    " #"@:Q4&445]3<!   G @  #P   'AL+W=O
M<FMB;V]K+GAM;(U1T6[", S\E2H?L!:T(0U17D#;D*8-C8GWT+K4(HDKQX6-
MKY_;JAK27O:4W-FZW%T6%^+3@>B4?'D78FYJD6:>IK&HP=MX1PT$G53$WHI"
M/J:Q8;!EK '$NW2:9;/46PQFN1BUMIS> A(H!"DHV1%[A$O\G7<P.6/$ SJ4
M[]ST=P<F\1C0XQ7*W&0FB35=7HCQ2D&LVQ5,SN5F,@SVP(+%'WK7F?RTA]@S
M8@\?5HWD9I:I8(4<I=_H]:UZ/(,N#Z@5>D(GP&LK\,S4-AB.G8RF2&]B]#V,
MYU#BG/]3(U45%K"FHO409.B1P74&0ZRQB28)UD-N5G0&3K;V"%TH?653#@%%
MG=W4Q7/4 6_*P>-HK(0* Y1OJA65UY**+2?=T>M,[Q\FCUI&Z]Q*N??P2K8<
M<XY_M/P!4$L#!!0    ( ,*!K%0D'INBK0   /@!   :    >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2
MQ:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/
M:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X\ \PO%WHJ45D
M*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-
MXPFNWPQP>'3^ 5!+ P04    " #"@:Q499!YDAD!  #/ P  $P   %M#;VYT
M96YT7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=< %C3QJK_I-G
M6M+;,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y
M2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-F<!B63R-PLQJ
M2AFC-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5
MZ*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(
MRDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X
M>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( ,*!K%0'04UB
M@0   +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L!
M A0#%     @ PH&L5 N :4WN    *P(  !$              ( !KP   &1O
M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ PH&L5)E<G",0!@  G"<  !,
M             ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" #"@:Q4%ET5'RX$   ^$   &               @($-"   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ PH&L5)^@&_"Q @  X@P   T
M             ( !<0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #"@:Q4
MEXJ[',     3 @  "P              @ %-#P  7W)E;',O+G)E;'-02P$"
M% ,4    " #"@:Q4&445]3<!   G @  #P              @ $V$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ PH&L5"0>FZ*M    ^ $  !H
M         ( !FA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ PH&L5&60>9(9 0  SP,  !,              ( !?Q(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  R1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="flks-20220512.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.flex-pharma.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="flks-20220512.htm">flks-20220512.htm</File>
    <File>flks-20220512.xsd</File>
    <File>flks-20220512_lab.xml</File>
    <File>flks-20220512_pre.xml</File>
    <File>salarius-earningsrelease1q.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "flks-20220512.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "flks-20220512.htm"
     ]
    },
    "labelLink": {
     "local": [
      "flks-20220512_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "flks-20220512_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "flks-20220512.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "flks",
   "nsuri": "http://www.flex-pharma.com/20220512",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "flks-20220512.htm",
      "contextRef": "i7c4c92f244d84648ad94262aa286148b_D20220512-20220512",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.flex-pharma.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "flks-20220512.htm",
      "contextRef": "i7c4c92f244d84648ad94262aa286148b_D20220512-20220512",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.flex-pharma.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001615219-22-000081-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001615219-22-000081-xbrl.zip
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M+$&!@$[^4>?0PU"Z 'Q6^T<8$@U+)E;(#9QU^!%E#E!6O1S0\/Q3@8?X]*0
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MX1,)FRYA6*$JT9GK:41BA5WA<@$_G*21>[&-!C1&ES08<O2_F7FQ/F?NEQ3
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M><F/F8NYFZ\EY6?+<30<B"L2DB*JP,O!=>;O(-N"!>*"4Y"]8-=YPSCTDR[
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M#@O"3B=Z+@?UL0=>#'8FN+T4[![>X7",47>9C8NPO(SSF9FJ*("^PAA$-(@
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MB7><#^R_N?VA?^F?Q=]_\S]02P,$%     @ PH&L5)/;2LVG&P  EO(  !X
M  !S86QA<FEU<RUE87)N:6YG<W)E;&5A<V4Q<2YH=&WM/=E2XTBV[_<K<NB^
MW52$;+1XA9J*H(#J9BY%,>".NO,TD9;2=C:RY-:"R_/U<\[)E"QO8," %SJB
M"]"2R]G7U,>_G7X[:?WKZHSUDK[/KO[X?'%^PO9*!P??G9.#@]/6*?N]]?6"
M5<JFQ5H1#V*9R##@_L'!V>4>V^LER>#PX& X'):'3CF,N@>MZP,<JG+@AV$L
MRE[B[7WZB%?@7\&]3__S\6^E$CL-W;0O@H2YD>")\%@:RZ#+OGLBOF6EDG[J
M)!R,(MGM)<PV;9M]#Z-;><?5_40FOOB4C?/Q0/W]\8 F^=@.O=&GCYZ\8]+[
M^YZL-"S.3:?B5CN-BF5S7FNW:Z)2L2MPP?/$ORU8Y $\KMZ)DY$O_K[7ET&I
M)W#^0\LVR\W:(#D:2B_I'5JF^;][].RGCYTP2&#"" 90O^;C?/HH^UW&_016
MT.==\6^S_.>@N\?BR)V^HB;4DS4J@Q]'?1YU8?YVF"1A_[ *4]^)*)$N]TO<
ME]W@,!$_$GU;K\HVS<&/?",SVZ$7U+LN@$Q$>_<M_J&WLOMNZ(?1X4\F_7>$
M=TH=WI?^Z/#7$WBM'<E?C1CHIA2+2';4 ['\CP"0PI[HSZ':=AW>]V4@<I@3
MD&^XSR.9QNRJQZ,^=T5*0(C9M1B$41*SST@Z(H[9[_"6CV_&;"B3'OLBHSAA
M_TQY!*M6%/1%!CQP)??A[3CUX<E'[_O-H44C'<H$'G<GX%>Y'WXWJ>L"F#JI
M[X^ L_H#7R0"+E^5'*M685>1*)U?GK*O0B3(BE=1B(]K4)X>ST)J,^%Q[-TA
M"< .^T  $J# O"CM,D_<"3\<D% :1&$WXOW88#Z(IO8H!Y(,6 )\*5!BP4.)
M@ N>@&<]CF+18#SP6"Q<7WJB'R<\P3>R!V70DVVIGV/P3$#<#(]U!8M@^BB6
M;5C.Q<VIE3T<1HLI=, ]#_91\D4'-M< >&17(K5?O+0M9/PU0]8 @!DDR,)%
MC"'< 0><P2)$G(0@$)CX,1 N8JH3A7T&DK*7(Q;18O].,F'K!0 )ON,@2 %D
M&7.''7:3A.YM+_0](#L 7Q"F@8NP HK[1QH(9E4-@L\O/U6;1R0O>#!B$L :
MN&$:\2Z.PWT?-E88* G9@*.:D@-0ZX26.T 82V!)$8M!A -B</9%4IU&*[\R
M4MK<O>U&  &OI/'3H?^.7A);\]7=21AT1 0P%NP$H8L0O)!W@AVGG@S9=]%V
M.6BU&[<GO-37"&N%'A\9["L?,<M6:#-8%3#7.#)--BCWR^RLM6*83MHG4Z+F
MSS1.9&?TBF!>Q )V%8#Z^[<_;EK?+B<AQ/9_N_CV^8Q=GGV_^7Y^??:!_?)3
MP[:LHX7$:;#SP"VS_4L>>_PO B^[N;C^_P]SY'E;AH.)MYFK64B++60?%S01
MF"; '!$?2. ,1"8PC@0TD(P*!& 8V"400Y:@I4S"+AR@$H'E)(AW4!UH",&#
MLH^_<+2JPPA^10Z$R7 L)",)/SNY 11I PBGA 7 ';26_M+6D@@\&/ KC]P>
M<RP%L*6X<GTP3^R$*+7-H^^"]3@P40]N:;U "EMMGZB!@ZD#:$NE#Q /""2D
M+= &XFY/ B!!Q:01XFT67@C?2"#[P"CB-C9H8J E- +@Q5-^)SUV'"6]-#+8
MR=FW^X1@F>EE7ZL1>V/#5@:NGWJ"@02&5?V52N6/X6@<+8Q$^#YL#F4]K'X
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ML_QQ7AV<E_+T84V<>H6T6S:Y+9#B'DR(XE1(+%U^+)HGHD(D[=87\?L-Q_G
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M E!+ 0(4 Q0    ( ,*!K%0'>= ^%Q4  !*,   1              "  0
M  !F;&MS+3(P,C(P-3$R+FAT;5!+ 0(4 Q0    ( ,*!K%0+3MX"=0(  (H'
M   1              "  485  !F;&MS+3(P,C(P-3$R+GAS9%!+ 0(4 Q0
M   ( ,*!K%0H<C/%. H  +!=   5              "  >H7  !F;&MS+3(P
M,C(P-3$R7VQA8BYX;6Q02P$"% ,4    " #"@:Q46LRJ@*L&  !9,0  %0
M            @ %5(@  9FQK<RTR,#(R,#4Q,E]P<F4N>&UL4$L! A0#%
M  @ PH&L5)/;2LVG&P  EO(  !X              ( !,RD  '-A;&%R:75S
L+65A<FYI;F=S<F5L96%S93%Q+FAT;5!+!08     !0 % % !   610     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
